<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD004317.pub3" GROUP_ID="FERTILREG" ID="120702100116411660" MERGED_FROM="" MODIFIED="2013-10-16 12:33:38 +0100" MODIFIED_BY="Anja Helmerhorst" NOTES="&lt;p&gt;Exported from Review Manager 4.2.9&lt;br&gt;Exported from Review Manager 4.2.10&lt;/p&gt;" NOTES_MODIFIED="2013-10-09 11:16:50 -0400" NOTES_MODIFIED_BY="Laureen Lopez" REVIEW_NO="0038" REVMAN_SUB_VERSION="5.2.6 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="9.0">
<COVER_SHEET MODIFIED="2013-10-16 12:33:38 +0100" MODIFIED_BY="Anja Helmerhorst">
<TITLE>Strategies to improve adherence and acceptability of hormonal methods of contraception</TITLE>
<CONTACT MODIFIED="2013-10-16 12:33:38 +0100" MODIFIED_BY="Anja Helmerhorst"><PERSON ID="3B53A95682E26AA20114382D371E0DCB" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Laureen</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Lopez</LAST_NAME><EMAIL_1>llopez@fhi360.org</EMAIL_1><ADDRESS><DEPARTMENT>Clinical Sciences</DEPARTMENT><ORGANISATION>FHI 360</ORGANISATION><ADDRESS_1>P.O. Box 13950</ADDRESS_1><CITY>Research Triangle Park</CITY><ZIP>27709</ZIP><REGION>North Carolina</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 919 5447040 ext: 11443</PHONE_1><FAX_1>+1 919 5447261</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2013-10-16 12:33:38 +0100" MODIFIED_BY="Anja Helmerhorst"><PERSON ID="1FCB93DD82E26AA201A256C73F18972D" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Vera</FIRST_NAME><LAST_NAME>Halpern</LAST_NAME><EMAIL_1>vhalpern@fhi360.org</EMAIL_1><ADDRESS><DEPARTMENT>Clinical Sciences</DEPARTMENT><ORGANISATION>FHI 360</ORGANISATION><ADDRESS_1>PO Box 13950</ADDRESS_1><CITY>Research Triangle Park</CITY><ZIP>NC 27709</ZIP><REGION>North Carolina</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 919 5447040 ext. 11390</PHONE_1><FAX_1>+1 919 5447261</FAX_1></ADDRESS></PERSON><PERSON ID="3B53A95682E26AA20114382D371E0DCB" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Laureen</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Lopez</LAST_NAME><EMAIL_1>llopez@fhi360.org</EMAIL_1><ADDRESS><DEPARTMENT>Clinical Sciences</DEPARTMENT><ORGANISATION>FHI 360</ORGANISATION><ADDRESS_1>P.O. Box 13950</ADDRESS_1><CITY>Research Triangle Park</CITY><ZIP>27709</ZIP><REGION>North Carolina</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 919 5447040 ext: 11443</PHONE_1><FAX_1>+1 919 5447261</FAX_1></ADDRESS></PERSON><PERSON ID="4664" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>David</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Grimes</LAST_NAME><POSITION>Clinical Professor</POSITION><EMAIL_1>david_grimes@med.unc.edu</EMAIL_1><MOBILE_PHONE>919-656-7227</MOBILE_PHONE><ADDRESS><DEPARTMENT>Obstetrics and Gynecology</DEPARTMENT><ORGANISATION>University of North Carolina, School of Medicine</ORGANISATION><ADDRESS_1>CB#7570</ADDRESS_1><CITY>Chapel Hill</CITY><ZIP>27599-7570</ZIP><REGION>North Carolina</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>919-656-7227</PHONE_1></ADDRESS></PERSON><PERSON ID="50210443841464275485100125184050" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>Laurie</FIRST_NAME><MIDDLE_INITIALS>L</MIDDLE_INITIALS><LAST_NAME>Stockton</LAST_NAME><SUFFIX>MPH</SUFFIX><POSITION>Research Associate</POSITION><EMAIL_1>lstockton@fhi360.org</EMAIL_1><ADDRESS><DEPARTMENT>Health Services Research</DEPARTMENT><ORGANISATION>FHI360</ORGANISATION><ADDRESS_1>PO Box 13950</ADDRESS_1><CITY>Research Triangle Park</CITY><ZIP>27709</ZIP><REGION>North Carolina</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>1 919 544 7040 X11517</PHONE_1><FAX_1>1 919 544 7261</FAX_1></ADDRESS></PERSON><PERSON ID="13632" ROLE="AUTHOR"><FIRST_NAME>Maria</FIRST_NAME><MIDDLE_INITIALS>F</MIDDLE_INITIALS><LAST_NAME>Gallo</LAST_NAME><SUFFIX>PhD</SUFFIX><POSITION>Assistant Professor</POSITION><EMAIL_1>mgallo@cph.osu.edu</EMAIL_1><EMAIL_2>fjr4@cdc.gov</EMAIL_2><ADDRESS><DEPARTMENT>Division of Epidemiology</DEPARTMENT><ORGANISATION>The Ohio State University</ORGANISATION><ADDRESS_1>Room 324 Cunz Hall</ADDRESS_1><ADDRESS_2>1841 Neil Avenue</ADDRESS_2><CITY>Columbus</CITY><ZIP>43210-1351</ZIP><REGION>Ohio</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 919 3080144</PHONE_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2013-10-09 10:42:24 -0400" MODIFIED_BY="Laureen Lopez" NOTES="&lt;p&gt;Minor update: 11/04/08&lt;/p&gt;&lt;p&gt;New studies found but not yet included or excluded: 07/01/08&lt;/p&gt;&lt;p&gt;New studies found and included or excluded: 09/04/08&lt;/p&gt;" NOTES_MODIFIED="2013-10-09 10:42:24 -0400" NOTES_MODIFIED_BY="Laureen Lopez">
<UP_TO_DATE>
<DATE DAY="4" MONTH="9" YEAR="2013"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="4" MONTH="9" YEAR="2013"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="17" MONTH="10" YEAR="2013"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2003"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="2006"/>
<LAST_CITATION_ISSUE ISSUE="4" YEAR="2011"/>
</DATES>
<WHATS_NEW MODIFIED="2013-09-04 10:26:08 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;The searches were updated in January and February of 2008.  No new trials were included.  Two new trials were excluded (Roye 2007; Schunmann 2006).&lt;/p&gt;" NOTES_MODIFIED="2013-09-04 10:26:08 -0400" NOTES_MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-09-04 10:26:08 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="4" MONTH="9" YEAR="2013"/>
<DESCRIPTION>
<P>Searches were updated. </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2013-07-30 13:34:53 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="24" MONTH="7" YEAR="2013"/>
<DESCRIPTION>
<P>Three new trials were included (<LINK REF="STD-Berenson-2012" TYPE="STUDY">Berenson 2012</LINK>; <LINK REF="STD-Casta_x00f1_o-2012" TYPE="STUDY">Castaño 2012</LINK>; <LINK REF="STD-Trent-2013" TYPE="STUDY">Trent 2013</LINK>).<BR/>One ongoing trial was added (<LINK REF="STD-Smith-2013" TYPE="STUDY">Smith 2013</LINK>).<BR/>
</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2013-07-24 05:04:31 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="23" MONTH="7" YEAR="2013"/>
<DESCRIPTION>
<P>Excluded two unpublished trials that were previously included (<LINK REF="STD-Andolsek-1982" TYPE="STUDY">Andolsek 1982</LINK>; <LINK REF="STD-Burnhill-1985" TYPE="STUDY">Burnhill 1985</LINK>). Further examination revealed they did not focus on hormonal methods of contraception.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2013-07-08 12:41:23 -0400" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2013-07-08 12:41:23 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="6" MONTH="1" YEAR="2011"/>
<DESCRIPTION>
<P>Two new trials were added (<LINK REF="STD-Hou-2010" TYPE="STUDY">Hou 2010</LINK>; <LINK REF="STD-Kirby-2010" TYPE="STUDY">Kirby 2010</LINK>), along with one ongoing study (Berenson 2010).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-07-08 09:29:25 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="23" MONTH="11" YEAR="2010"/>
<DESCRIPTION>
<P>Searches were updated for MEDLINE, CENTRAL, and POPLINE. New searches were conducted for ClinicalTrials.gov and ICTRP.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-10-06 16:27:33 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="21" MONTH="4" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="28" MONTH="9" YEAR="2005"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>U.S. Agency for International Development</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>National Institute of Child Health and Human Development</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2013-10-09 11:16:50 -0400" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2013-09-04 10:39:55 -0400" MODIFIED_BY="[Empty name]">
<TITLE>Ways to improve use of hormonal birth control</TITLE>
<SUMMARY_BODY MODIFIED="2013-09-04 10:39:55 -0400" MODIFIED_BY="[Empty name]">
<P>Hormonal types of birth control are used by many women worldwide. The most common hormonal methods are birth control pills and injections. These methods often do not work as well as they could. Women may have problems using the birth control as planned. They may miss taking some pills. Other women may stop using a method due to bleeding changes. This review looked at whether more counseling or reminders helped women use these types of birth control.</P>
<P>Through August 2013, we did computer searches for randomized trials comparing special counseling with usual counseling. In addition, we looked at reference lists to find trials. We also wrote to researchers to find more studies.</P>
<P>We found nine trials. Five studies counseled women about the method and its side effects. Four trials focused on reminders for appointments or pill-taking, but two also provided health information. Three trials showed some positive results. One study gave structured counseling about an injected type of birth control. More women who got the structured counseling kept using the birth control than women who had the usual counseling. Also, fewer women who had the structured counseling stopped using the birth control due to bleeding changes. Another study gave special counseling with or without follow-up calls. In the short-term, more women with counseling and phone calls said they took the birth control pills regularly than those without phone calls or those with usual care. The third study sent text-message reminders to cell phones about birth control pills plus health information. More women in the text-message group were still taking their pills at six months than women with standard care.</P>
<P>Only three studies showed better results with the special counseling or reminders. Four trials had few women in them and six lost many women during the study. The studies had moderate quality data. To prevent pregnancy, women should use birth control as planned and should keep using it. More trials of good quality are needed to learn how to help women use their birth control method.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2013-09-04 12:48:54 -0400" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2013-08-27 09:46:04 -0400" MODIFIED_BY="[Empty name]">
<P>Worldwide, hormonal contraceptives are among the most popular reversible contraceptives. Despite their high theoretical effectiveness, typical use results in much lower effectiveness. In large part, this disparity reflects difficulties in adherence to the contraceptive regimen and low rates for long-term continuation.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2013-09-04 12:48:54 -0400" MODIFIED_BY="[Empty name]">
<P>The intent was to determine the effectiveness of ancillary counseling techniques to improve adherence to, and continuation of, hormonal methods of contraception.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2013-09-04 10:39:32 -0400" MODIFIED_BY="[Empty name]">
<P>Through August 2013, we searched computerized databases for randomized controlled trials (RCTs) comparing client-provider interventions with standard family planning counseling. Sources included CENTRAL, MEDLINE, EMBASE, POPLINE, ClinicalTrials.gov and ICTRP. Earlier searches also included LILACS, PsycINFO, Dissertation Abstracts, African Index Medicus, and IMEMR.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2013-08-14 08:32:20 -0400" MODIFIED_BY="[Empty name]">
<P>We included RCTs of an intensive counseling technique or other client-provider intervention compared to routine family planning counseling. Interventions included group motivation; structured, peer, or multi-component counseling; and intensive reminders of appointments or next dosing. Outcome measures were discontinuation, reasons for discontinuation, number of missed pills or on-time injections, and pregnancy.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2013-09-04 10:39:41 -0400" MODIFIED_BY="[Empty name]">
<P>One author evaluated the titles and abstracts from the searches to determine eligibility. Two authors extracted data from the included studies. We calculated the Mantel-Haenszel odds ratio (OR) for dichotomous outcomes. For continuous variables, the mean difference (MD) was computed; RevMan uses the inverse variance approach. For all analyses, 95% confidence intervals (CI) were also computed. Since the studies identified differed in both interventions and outcome measures, we did not conduct a meta-analysis.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2013-08-14 14:33:43 -0400" MODIFIED_BY="[Empty name]">
<P>Nine RCTs met our inclusion criteria. Five involved direct counseling; of those, two also provided multiple contacts by telephone. Four other trials provided intensive reminders, two of which also provided health education information. Three trials showed some benefit of the experimental intervention. In a counseling intervention, women who received repeated structured information about the injectable depot medroxyprogesterone acetate (DMPA) were less likely to discontinue the method by 12 months (OR 0.27; 95% CI 0.16 to 0.44) than women who had routine counseling. The intervention group was also less likely to discontinue due to menstrual disturbances (OR 0.20; 95% CI 0.11 to 0.37). Another trial showed a group with special counseling plus phone calls was more likely than the special-counseling group to report consistent use of oral contraceptives (OC) at 3 months (OR 1.41; 95% CI 1.06 to 1.87), though not at 12 months. The group with only special counseling did not differ significantly from those with standard care for any outcome. The third trial compared daily text-message reminders about OCs plus health information versus standard care. Women in the text-message group were more likely than the standard-care group to continue OC use by six months (OR 1.54; 95% CI 1.14 to 2.10). The text-message group was also more likely to avoid an interruption in OC use longer than seven days (OR 1.53; 95% CI 1.13 to 2.07).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2013-09-04 11:07:06 -0400" MODIFIED_BY="[Empty name]">
<P>Only three trials showed some benefit of strategies to improve adherence and continuation. However, several had small sample sizes and six had high losses to follow up. The overall quality of evidence was considered moderate. The intervention type and intensity varied greatly across the studies. A combination of intensive counseling and multiple contacts and reminders may be needed to improve adherence and acceptability of contraceptive use. High-quality RCTs with adequate power and well-designed interventions could help identify ways to improve adherence to, and continuation of, hormonal contraceptive methods.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2013-10-09 11:16:50 -0400" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2013-10-09 10:48:06 -0400" MODIFIED_BY="[Empty name]">
<P>Worldwide, hormonal contraceptives are among the most popular reversible methods of family planning. About 18% of married women in higher resource countries report using oral contraceptives (OCs) (<LINK REF="REF-UN-2011" TYPE="REFERENCE">UN 2011</LINK>), as have 17% of women in the USA (<LINK REF="REF-Jones-2012" TYPE="REFERENCE">Jones 2012</LINK>). In lower resource areas, the figure for OC use is 7%. The injectable depot medroxyprogesterone acetate (DMPA) is used by an estimated 3.5% of women globally (<LINK REF="REF-UN-2011" TYPE="REFERENCE">UN 2011</LINK>), including 2.3% of women in the USA (<LINK REF="REF-Jones-2012" TYPE="REFERENCE">Jones 2012</LINK>). Therefore, more than 145 million women worldwide report using hormonal contraceptives (<LINK REF="REF-UN-2011" TYPE="REFERENCE">UN 2011</LINK>).</P>
<P>Despite high theoretical effectiveness of hormonal methods, typical use has less favorable results. For example, in the USA, the first-year failure rate for typical use of OCs is about 9%, whereas it is only 0.3% for perfect use (<LINK REF="REF-Trussell-2011" TYPE="REFERENCE">Trussell 2011</LINK>). The wide gap between theoretical and actual effectiveness is attributed to human factors. Several types of hormonal contraceptives depend on adherence to the regimen, which is often called 'compliance' in the medical literature. Repetitive and correct use by the woman is critical for successful use of OCs, progestin-only pills, the transdermal patch, the vaginal ring, and to some extent injectable contraceptives. In contrast, the effectiveness of long-acting hormonal contraceptives, such as the levonorgestrel intrauterine system (LNG IUS) and subdermal delivery systems (i.e., implants), depend less on remembering to use them. In those cases, continuation, rather than adherence to the regimen, determines success.</P>
<P>Hormonal contraceptives in general are characterized by both poor adherence and relatively high discontinuation rates. Reasons include hormonal side effects (<LINK REF="REF-Davie-1996" TYPE="REFERENCE">Davie 1996</LINK>; <LINK REF="REF-Lei-1996" TYPE="REFERENCE">Lei 1996</LINK>), problems with access (<LINK REF="REF-White-2011" TYPE="REFERENCE">White 2011</LINK>), or confusion about pill-taking instructions (<LINK REF="REF-Westhoff-2007" TYPE="REFERENCE">Westhoff 2007</LINK>). Nearly half of OC users miss one or more pills each month, and more than a fifth miss two or more (<LINK REF="REF-Rosenberg-1998" TYPE="REFERENCE">Rosenberg 1998</LINK>). Difficulties in correct pill-taking may lead to discontinuation and to unintended pregnancy. Analysis of an insurance claims database in the USA indicated more than 35% of new OC users did not refill their prescriptions at three months (<LINK REF="REF-Murphy-2008" TYPE="REFERENCE">Murphy 2008</LINK>). Also in the USA, prescription refills for hormonal contraceptives were analyzed, and included the vaginal ring, transdermal patch, OCs, and DMPA (<LINK REF="REF-Nelson-2008" TYPE="REFERENCE">Nelson 2008</LINK>). By three months, only 48% to 61% of women had timely prescription refills, depending on the contraceptive method. A randomized trial showed OC discontinuation of 51% for adolescents provided with seven pills packs and 35% for those given three packs (<LINK REF="REF-White-2011" TYPE="REFERENCE">White 2011</LINK>). In Brazil, 45% of pill users discontinued in the first 12 months; 12% due to side effects (<LINK REF="REF-Leite-2007" TYPE="REFERENCE">Leite 2007</LINK>). Unintended pregnancies related to OC use are estimated to account for 20% of the 3.5 million annual unintended pregnancies in the USA (<LINK REF="REF-Rosenberg-1995" TYPE="REFERENCE">Rosenberg 1995</LINK>; <LINK REF="REF-Rosenberg-1999" TYPE="REFERENCE">Rosenberg 1999</LINK>). The cumulative discontinuation figures for levonorgestrel subdermal implants range from 10% to 13% at one year to 28% at two years (<LINK REF="REF-Fleming-1998" TYPE="REFERENCE">Fleming 1998</LINK>; <LINK REF="REF-Glasier-2002" TYPE="REFERENCE">Glasier 2002</LINK>). A review of multinational data reported 43% discontinuation for the single-rod implant by three years (<LINK REF="REF-NCCWCH-2005" TYPE="REFERENCE">NCCWCH 2005</LINK>). For DMPA, multinational data indicate 50% discontinuation for DMPA at one year (<LINK REF="REF-NCCWCH-2005" TYPE="REFERENCE">NCCWCH 2005</LINK>). In Brazil, the discontinuation rate for injectables was 64% for the first 12 months, with 27% related to side effects (<LINK REF="REF-Leite-2007" TYPE="REFERENCE">Leite 2007</LINK>).</P>
<P>An 'ideal' contraceptive would be characterized by easy use, minimal side effects, excellent tolerability, and high continuation rates. The search for such a contraceptive led to the introduction of low-dose pills and combined injectables, as well as new contraceptive delivery systems, such as the transdermal patch, hormone-releasing intrauterine system, and intravaginal ring. Low-dose contraceptives were developed over a 20-year period and have less estrogen than their predecessors. The estrogen reduction was intended to lower risk of adverse health events while combining estrogen and progestin to maintain efficacy (<LINK REF="REF-Gallo-2013" TYPE="REFERENCE">Gallo 2013</LINK>). Combined injectable contraceptives contain a progestin plus an estrogen. They were developed to address negative side effects of progestin-only formulations; some have better bleeding patterns than progestin-only injectables (<LINK REF="REF-Bartz-2011" TYPE="REFERENCE">Bartz 2011</LINK>). However, the new methods have not been associated with substantial improvement in contraceptive continuation or adherence. OCs containing 20 &#956;g of ethinyl estradiol had higher discontinuation rates, which were related to more irregular bleeding (<LINK REF="REF-Gallo-2013" TYPE="REFERENCE">Gallo 2013</LINK>). For the combined monthly injectable containing medroxyprogesterone acetate (MPA) and estradiol cypionate, continuation in the first year was reportedly 52% (<LINK REF="REF-Hall-1997" TYPE="REFERENCE">Hall 1997</LINK>). About 15% of treatment cycles while using the vaginal ring were not consistent with the dosing regimen (<LINK REF="REF-Dieben-2002" TYPE="REFERENCE">Dieben 2002</LINK>). The women had ring-free time periods that were longer, shorter, or more frequent than recommended. During the first year of use, at least 25% of women discontinued the LNG IUS, often considered close to an 'ideal' contraceptive (<LINK REF="REF-Diaz-2000" TYPE="REFERENCE">Diaz 2000</LINK>). A review of international data indicated 60% discontinuation at five years for users of an intrauterine device (IUD) or LNG IUS (<LINK REF="REF-NCCWCH-2005" TYPE="REFERENCE">NCCWCH 2005</LINK>).</P>
<P>Given that even close to ideal methods are characterized by far from ideal adherence or continuation, contraceptive continuation may depend on factors other than method characteristics and the woman's willingness or ability to follow the regimen. The quality of family planning services may affect contraceptive acceptability and continuation. Within the first year of starting a method, 7% to 27% of women stop using contraception for reasons that could be addressed during family planning counseling, including side effects and health concerns related to the contraceptive method (<LINK REF="REF-Blanc-2002" TYPE="REFERENCE">Blanc 2002</LINK>). Quality of services is defined by provider skills, quality of information provided, client-provider interactions, and continuity of care (<LINK REF="REF-Jain-1989" TYPE="REFERENCE">Jain 1989</LINK>; <LINK REF="REF-Blanc-2002" TYPE="REFERENCE">Blanc 2002</LINK>; <LINK REF="REF-ARHP-2004" TYPE="REFERENCE">ARHP 2004</LINK>). An individualized approach to family planning services would focus on individual needs assessment and interpersonal relations between the consumer and the provider (<LINK REF="REF-Rudy-2003" TYPE="REFERENCE">Rudy 2003</LINK>; <LINK REF="REF-ARHP-2004" TYPE="REFERENCE">ARHP 2004</LINK>).</P>
<P>An important component of family planning service is providing the client with objective and harmonized information about contraceptive methods. Various counseling interventions are aimed to cover knowledge gaps about correct contraceptive use (<LINK REF="REF-Little-1998" TYPE="REFERENCE">Little 1998</LINK>) and typical side effects (<LINK REF="REF-Blanc-2002" TYPE="REFERENCE">Blanc 2002</LINK>), to improve the woman's understanding of the method and the consequences of inaccurate use. The available data that counseling improves contraceptive knowledge and use. A Canadian survey indicated that women who had counseling also had more accurate responses on the majority of questions about OC use, benefits, and side effects (<LINK REF="REF-Gaudet-2004" TYPE="REFERENCE">Gaudet 2004</LINK>). Client-provider relations and information provided can affect contraceptive acceptability and continuation (<LINK REF="REF-Jain-1989" TYPE="REFERENCE">Jain 1989</LINK>).</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2013-09-04 12:49:04 -0400" MODIFIED_BY="[Empty name]">
<P>The intent was to determine the effectiveness of ancillary counseling techniques to improve adherence to, and continuation of, hormonal methods of contraception.</P>
</OBJECTIVES>
<METHODS MODIFIED="2013-09-04 10:39:23 -0400" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2013-08-13 16:26:13 -0400" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2013-08-13 16:26:13 -0400" MODIFIED_BY="[Empty name]">
<P>Eligible studies were randomized controlled trials of one or more intensive counseling techniques or other client-provider interventions (any type) versus routine family planning counseling approaches for the improvement of adherence and continuation.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Eligible participants were women of reproductive age without medical contraindications to hormonal methods of contraception.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2011-03-07 09:24:15 -0500" MODIFIED_BY="[Empty name]">
<P>Eligible interventions were client-provider interventions such as group motivation; structured, peer or multi-component counseling; and intensive reminders of follow-up appointments or next dosing. These were designed to facilitate the use of hormonal methods of contraception and compared to routine methods of family planning counseling.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2013-07-18 08:47:44 -0400" MODIFIED_BY="[Empty name]">
<P>Outcome measures included the following:</P>
<UL>
<LI>discontinuation and reasons for discontinuation</LI>
<LI>number of missed pills</LI>
<LI>number of on-time injections</LI>
<LI>pregnancy.</LI>
</UL>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2013-09-04 10:39:23 -0400" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2013-09-04 10:39:23 -0400" MODIFIED_BY="[Empty name]">
<P>Through August 2013, we searched the following computerized databases for randomized controlled trials (RCTs) comparing client-provider interventions with standard family planning counseling: Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE using PubMed, POPLINE, and EMBASE. We searched for recent trials via ClinicalTrials.gov and the search portal of the International Clinical Trials Registry Platform (ICTRP). Strategies are shown in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>. Strategies for the 2011 update can be found in <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>. For the initial review (2005) and the 2008 update, the search also included LILACS, PsycINFO, Dissertation Abstracts Online, African Index Medicus, and IMEMR (<LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2013-07-08 14:47:56 -0400" MODIFIED_BY="[Empty name]">
<P>For the initial review, we examined the reference lists of identified articles and wrote to experts in the field to seek trials we might have missed. We unsuccessfully attempted to locate and contact the authors of two unpublished randomized trials for more information about their studies.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2013-08-14 11:00:29 -0400" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2013-08-14 10:58:54 -0400" MODIFIED_BY="[Empty name]">
<P>One author evaluated the titles and abstracts in the literature searches to determine whether they met the inclusion criteria. A second author also examined the reports identified for appropriate categorization.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2013-07-18 08:55:38 -0400" MODIFIED_BY="[Empty name]">
<P>One author extracted the data and entered the information into RevMan. This includes the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> and the outcome data (<LINK TAG="ANALYSES_AND_DATA" TYPE="SECTION">Data and analyses</LINK>; <LINK TAG="ADDITIONAL_TABLES" TYPE="SECTION">Additional tables</LINK>). Another author conducted a second data extraction and verified correct data entry. Any discrepancies were resolved by discussion.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2013-08-14 10:59:38 -0400" MODIFIED_BY="[Empty name]">
<P>We assessed the methodological quality of the trials using recommended methods (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We focused on the method of randomization; the number of women randomized and excluded or lost to follow up; and the use of allocation concealment and blinding.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2013-07-18 12:51:35 -0400" MODIFIED_BY="[Empty name]">
<P>We calculated the Mantel-Haenszel odds ratio (OR) for dichotomous outcomes. For continuous variables, the mean difference (MD) was computed; RevMan uses the inverse variance approach. For all analyses, 95% confidence intervals (CI) were also computed. Any discrepancies were resolved by discussion. Since the studies identified were so different in both exposures and outcomes, we did not conduct a meta-analysis.</P>
</EFFECT_MEASURES>
<MISSING_DATA MODIFIED="2013-08-14 11:00:29 -0400" MODIFIED_BY="[Empty name]">
<P>We wrote to the investigators of potentially eligible studies to request additional information if needed.</P>
</MISSING_DATA>
<DATA_SYNTHESIS MODIFIED="2013-08-14 10:46:05 -0400" MODIFIED_BY="[Empty name]">
<P>The quality of the evidence was assessed using GRADE principles (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We summarized the quality of evidence for each study. For the 2013 update, we added a category for randomization and allocation concealment. Grade levels were high, moderate, low, or very low. RCTs were considered high quality and then downgraded for each of the following: a) randomization sequence generation and allocation concealment: no information on either or one was inadequate; b) losses to follow up were 20% or greater; c) all outcomes were self-reported or data were unavailable on objective outcomes; d) intervention focused on reminders without additional health education.</P>
</DATA_SYNTHESIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2013-09-04 10:41:42 -0400" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2013-09-04 10:41:42 -0400" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2013-07-30 14:22:19 -0400" MODIFIED_BY="[Empty name]">
<P>The 2013 search resulted in 63 unduplicated references. From the main databases, we obtained 36 citations. In addition, we identified 24 ongoing clinical trials, and we obtained three articles from other sources such as reference lists.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2013-09-04 10:41:42 -0400" MODIFIED_BY="[Empty name]">
<P>Nine RCTs met the criteria for inclusion in the review. One was multi-site (<LINK REF="STD-Berenson-2012" TYPE="STUDY">Berenson 2012</LINK>) and eight were single-site (<LINK REF="STD-Jay-1984" TYPE="STUDY">Jay 1984</LINK>, <LINK REF="STD-Keder-1998" TYPE="STUDY">Keder 1998</LINK>; <LINK REF="STD-Canto-De-Cetina-2001" TYPE="STUDY">Canto De Cetina 2001</LINK>; <LINK REF="STD-Gilliam-2004" TYPE="STUDY">Gilliam 2004</LINK>; <LINK REF="STD-Hou-2010" TYPE="STUDY">Hou 2010</LINK>; <LINK REF="STD-Kirby-2010" TYPE="STUDY">Kirby 2010</LINK>; <LINK REF="STD-Casta_x00f1_o-2012" TYPE="STUDY">Castaño 2012</LINK>; <LINK REF="STD-Trent-2013" TYPE="STUDY">Trent 2013</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">Counseling interventions</HEADING>
<P>Five trials provided direct in-person counseling. Of those, two also provided multiple contacts by telephone (<LINK REF="STD-Kirby-2010" TYPE="STUDY">Kirby 2010</LINK>; <LINK REF="STD-Berenson-2012" TYPE="STUDY">Berenson 2012</LINK>).</P>
<P>
<LINK REF="STD-Jay-1984" TYPE="STUDY">Jay 1984</LINK> compared peer counseling with nurse counseling to improve adolescent adherence to OCs. Inclusion and exclusion criteria were not specified. From an adolescent gynecology clinic in Georgia (USA), 57 females wanted to use OCs and agreed to participate in the study. They were randomly assigned to the peer-counselor or nurse-counselor group. All participants were followed up at one, two, and four months. Non-adherence was measured with a four-factor Guttman scale that included 1) became pregnant during the previous month, 2) missed appointment, 3) reported missing three or more OCs during the month, and 4) had absence of urinary fluorescence at the follow up. The latter is a method for monitoring the use of the prescribed OC and riboflavin pill (<LINK REF="REF-Silberstein-1966" TYPE="REFERENCE">Silberstein 1966</LINK>). The four-month loss rate included failing to keep the second rescheduled appointment that had been broken or discontinuing the OC regimen.</P>
<P>
<LINK REF="STD-Canto-De-Cetina-2001" TYPE="STUDY">Canto De Cetina 2001</LINK> compared structured counseling with routine counseling to improve adherence in women receiving DMPA for contraception. The study enrolled 350 women at a family planning clinic in Merida, Yucatan (Mexico), who chose DMPA for contraception. Structured pre-treatment counseling was provided through a uniform set of audiovisual messages on risks, benefits, and overall characteristics of the injectable contraceptive. The information included the mode of action of DMPA and common side effects. The counseling emphasized the potential side effects would not be detrimental to the participant's health. These indications were repeated at each follow-up visit. Women were encouraged to return to the clinic for any DMPA-related concerns. Participants in the control group received routine information on the expected side effects of DMPA. The study assessed side effects, discontinuation at 12 months, and reasons for discontinuation. The cumulative discontinuation at 12 months included those lost to follow up.</P>
<P>
<LINK REF="STD-Gilliam-2004" TYPE="STUDY">Gilliam 2004</LINK> provided an antepartum, multi-component intervention that included counseling, a videotape about oral contraceptives (OCs), and written material about OCs. The comparison was resident-physician counseling, which aimed to increase adherence to OCs and decrease repeat unplanned pregnancies in young women. Women in the intervention group received one-on-one counseling by a nurse, watched the videotape, and received six informational sheets, which the nurse reviewed. The study enrolled 43 women during their antepartum visits, but not all used OCs. The study randomized 33 women and assessed adherence to OCs at one year as still using OCs, switched to a different method, not using contraception, and pregnancy. Data were collected at enrollment (between 34 weeks and term); immediately following the intervention; and at 6 weeks, 6 months, and 12 months postpartum.</P>
<P>The intervention in <LINK REF="STD-Kirby-2010" TYPE="STUDY">Kirby 2010</LINK> used motivational interviewing via phone calls to improve contraceptive use among adolescents. From a reproductive health clinic in San Francisco, CA (USA), 805 young women were enrolled. Over 12 months, up to nine calls could be provided, which were monthly for the first 6 months and then every other month. The comparison group had usual care from the reproductive health clinic, which only made calls to report abnormal results or respond to patients' inquiries. The relevant outcomes were pregnancy (self-report) and correct use of hormonal contraceptives (DMPA, transdermal patch, and OCs).</P>
<P>
<LINK REF="STD-Berenson-2012" TYPE="STUDY">Berenson 2012</LINK> was conducted in five public clinics for reproductive health in southeast Texas (USA). A total of 1155 women were randomized to one of three study arms: 1) Standard care from nurse practitioner with written protocol for new OC users; 2) Counseling included standard care plus 45 minutes of contraceptive counseling from study staff; 3) Counseling plus phone calls by contraceptive counselor, which occurred weekly until initiation and then monthly for 6 months, as well as access to a 24-hour toll-free number. The intervention duration was six months, with telephone follow up at 3, 6 and 12 months. The relevant outcomes were OC adherence (assessed as consistent OC use) and pregnancy, which was obtained from self-report as well as review of all medical records at the end of study.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Intensive reminders</HEADING>
<P>Four trials provided intensive reminders of appointments or next dosing. The older study used mail and telephone (<LINK REF="STD-Keder-1998" TYPE="STUDY">Keder 1998</LINK>). The three newer trials sent text messages to cell phones, two of which also provided educational text messages (<LINK REF="STD-Casta_x00f1_o-2012" TYPE="STUDY">Castaño 2012</LINK>; <LINK REF="STD-Trent-2013" TYPE="STUDY">Trent 2013</LINK>).</P>
<P>In <LINK REF="STD-Keder-1998" TYPE="STUDY">Keder 1998</LINK>, a system of intensive reminders was compared to the regular written appointment cards to improve adherence to DMPA. The trial enrolled 250 women who selected DMPA for contraception while attending a hospital clinic in Pittsburgh, Pennsylvania (USA). All women were given a written appointment card for their next injection, scheduled for 12 weeks. The reminder group also received mail and telephone reminders. They were sent a letter two weeks before each scheduled injection, and were called if they failed to keep their appointment. The trial evaluated discontinuation at 12 months, degree of satisfaction, side effects, reasons for discontinuation, and number of on-time injections. We combined those lost to follow up and the discontinued participants to analyze discontinuation rates at 12 months. Participants who received their DMPA injections within 14 weeks of the prior injection were classified as 'on-time.'</P>
<P>In <LINK REF="STD-Hou-2010" TYPE="STUDY">Hou 2010</LINK>, the experimental group received daily text messages to remind them to take their OCs. Controls were not sent reminders. The 82 participants were recruited from a family planning clinic in Boston, MA (USA). They had to have a personal mobile phone with text-messaging capability. Outcomes included the number of missed pills per cycle, which were measured with an electronic monitoring device and diaries. Cycles one through three were assessed; we analyzed the first and third in this review.</P>
<P>
<LINK REF="STD-Casta_x00f1_o-2012" TYPE="STUDY">Castaño 2012</LINK> focused on OC continuation among young women, and was conducted in a family planning health center in Brooklyn, NY (USA). Routine care included contraceptive counseling and a handout. The experimental intervention included routine care plus 180 daily text messages. The messages provided reminders to take OCs daily and addressed six domains of OC knowledge. i.e., risks, benefits, side effects, use, effectiveness, and mechanisms of action. OC continuation, i.e., participant reported taking pill during the last 7 days, was assessed by phone at six months. Also assessed were no missed pills, interruptions in OC use longer than seven days, and use of OC at last sexual intercourse.</P>
<P>The pilot project of <LINK REF="STD-Trent-2013" TYPE="STUDY">Trent 2013</LINK> addressed adherence to appointments for DMPA injections among young women. The location was an urban academic practice in Baltimore, MD (USA). Standard of care included counseling and clinic appointment reminders, as well as a call from nurse case manager after missing a scheduled re-injection appointment. The experimental intervention included daily text appointment reminders, starting 72 hours before a scheduled clinical visit; monthly health messages on use of condoms, weight control, DMPA side effect management, and an STD testing reminder; and a call for missed appointment or for no reply to an appointment reminder (or other text message).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Outcomes</HEADING>
<P>Four trials reported on discontinuation (<LINK REF="STD-Keder-1998" TYPE="STUDY">Keder 1998</LINK>; <LINK REF="STD-Canto-De-Cetina-2001" TYPE="STUDY">Canto De Cetina 2001</LINK>) or continuation (<LINK REF="STD-Gilliam-2004" TYPE="STUDY">Gilliam 2004</LINK>; <LINK REF="STD-Casta_x00f1_o-2012" TYPE="STUDY">Castaño 2012</LINK>). <LINK REF="STD-Jay-1984" TYPE="STUDY">Jay 1984</LINK> provided data on attrition.</P>
<P>Seven trials assessed adherence: on-time injections (<LINK REF="STD-Keder-1998" TYPE="STUDY">Keder 1998</LINK>; <LINK REF="STD-Trent-2013" TYPE="STUDY">Trent 2013</LINK>); non-compliance (<LINK REF="STD-Jay-1984" TYPE="STUDY">Jay 1984</LINK>); switched contraceptives (<LINK REF="STD-Gilliam-2004" TYPE="STUDY">Gilliam 2004</LINK>); missed pills (<LINK REF="STD-Hou-2010" TYPE="STUDY">Hou 2010</LINK>; <LINK REF="STD-Casta_x00f1_o-2012" TYPE="STUDY">Castaño 2012</LINK>); or consistent OC use (<LINK REF="STD-Berenson-2012" TYPE="STUDY">Berenson 2012</LINK>).</P>
<P>Three trials had pregnancy as an outcome (<LINK REF="STD-Gilliam-2004" TYPE="STUDY">Gilliam 2004</LINK>; <LINK REF="STD-Kirby-2010" TYPE="STUDY">Kirby 2010</LINK>; <LINK REF="STD-Berenson-2012" TYPE="STUDY">Berenson 2012</LINK>). However, <LINK REF="STD-Gilliam-2004" TYPE="STUDY">Gilliam 2004</LINK> obtained pregnancy data for a limited number of participants.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2013-08-14 14:54:20 -0400" MODIFIED_BY="[Empty name]">
<P>In 2013, we excluded two unpublished trials that were included in the original review (<LINK REF="STD-Andolsek-1982" TYPE="STUDY">Andolsek 1982</LINK>; <LINK REF="STD-Burnhill-1985" TYPE="STUDY">Burnhill 1985</LINK>). We re-examined the reports to synthesize the results, given the greater number of studies in the update. We noted that the outcome measures for <LINK REF="STD-Andolsek-1982" TYPE="STUDY">Andolsek 1982</LINK> were not limited to hormonal methods, but rather grouped hormonal and non-hormonal methods. We had included discontinuation data earlier, but only found one significant difference (in dissatisfaction with method). The intervention in <LINK REF="STD-Burnhill-1985" TYPE="STUDY">Burnhill 1985</LINK> was individualized, and apparently did not focus on hormonal methods. No data had been included from that report due to unclear denominators. Exclusion of these trials did not affect the overall review conclusions.</P>
<P>Six new trials were excluded in 2013 (<LINK REF="STD-Gilliam-2010" TYPE="STUDY">Gilliam 2010</LINK>; <LINK REF="STD-Langston-2010" TYPE="STUDY">Langston 2010</LINK>; <LINK REF="STD-Carneiro-2011" TYPE="STUDY">Carneiro 2011</LINK>; <LINK REF="STD-Behboodi-2013" TYPE="STUDY">Behboodi 2013</LINK>; <LINK REF="STD-Madden-2013" TYPE="STUDY">Madden 2013</LINK>; <LINK REF="STD-Schwandt-2013" TYPE="STUDY">Schwandt 2013</LINK>). Some interventions and outcome measures were not specific to hormonal methods. Others did not have relevant outcome measures for this review. Details are provided in <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2013-08-29 09:53:43 -0400" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="STD-Trent-2013" TYPE="STUDY">Trent 2013</LINK> was recently completed; a conference abstract provided the only outcome data. Design information came from the listing in ClinicalTrials.gov.</P>
<ALLOCATION MODIFIED="2013-07-30 14:25:10 -0400" MODIFIED_BY="[Empty name]">
<P>Randomization methods were specified for seven trials that used computer-generated sequences (<LINK REF="STD-Jay-1984" TYPE="STUDY">Jay 1984</LINK>; <LINK REF="STD-Keder-1998" TYPE="STUDY">Keder 1998</LINK>; <LINK REF="STD-Gilliam-2004" TYPE="STUDY">Gilliam 2004</LINK>; <LINK REF="STD-Hou-2010" TYPE="STUDY">Hou 2010</LINK>; <LINK REF="STD-Kirby-2010" TYPE="STUDY">Kirby 2010</LINK>; <LINK REF="STD-Berenson-2012" TYPE="STUDY">Berenson 2012</LINK>; <LINK REF="STD-Casta_x00f1_o-2012" TYPE="STUDY">Castaño 2012</LINK>; <LINK REF="STD-Trent-2013" TYPE="STUDY">Trent 2013</LINK>). Three trials provided the method of allocation concealment (<LINK REF="STD-Gilliam-2004" TYPE="STUDY">Gilliam 2004</LINK>; <LINK REF="STD-Hou-2010" TYPE="STUDY">Hou 2010</LINK>; <LINK REF="STD-Casta_x00f1_o-2012" TYPE="STUDY">Castaño 2012</LINK>; <LINK REF="STD-Trent-2013" TYPE="STUDY">Trent 2013</LINK>).</P>
</ALLOCATION>
<BLINDING MODIFIED="2013-07-30 13:34:53 -0400" MODIFIED_BY="[Empty name]">
<P>Six trials had some blinding. Research team members were blinded to group participation in three studies (<LINK REF="STD-Gilliam-2004" TYPE="STUDY">Gilliam 2004</LINK>; <LINK REF="STD-Hou-2010" TYPE="STUDY">Hou 2010</LINK>; <LINK REF="STD-Trent-2013" TYPE="STUDY">Trent 2013</LINK>) and outcome assessment was blinded in three (<LINK REF="STD-Jay-1984" TYPE="STUDY">Jay 1984;</LINK> <LINK REF="STD-Kirby-2010" TYPE="STUDY">Kirby 2010</LINK>; <LINK REF="STD-Berenson-2012" TYPE="STUDY">Berenson 2012</LINK>). Of the remaining three trials, the investigators and research team members were not blinded in two (<LINK REF="STD-Keder-1998" TYPE="STUDY">Keder 1998</LINK>; <LINK REF="STD-Casta_x00f1_o-2012" TYPE="STUDY">Castaño 2012</LINK>), and one did not report whether any blinding was used (<LINK REF="STD-Canto-De-Cetina-2001" TYPE="STUDY">Canto De Cetina 2001</LINK>).</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2013-07-29 15:36:10 -0400" MODIFIED_BY="[Empty name]">
<P>Six trials had losses of 20% or more:</P>
<UL>
<LI>
<LINK REF="STD-Berenson-2012" TYPE="STUDY">Berenson 2012</LINK> lost 44%;</LI>
<LI>
<LINK REF="STD-Jay-1984" TYPE="STUDY">Jay 1984</LINK> reported losses of 42% and 23% in the nurse-counselor and peer-counselor groups, respectively, for 33% overall;</LI>
<LI>In <LINK REF="STD-Keder-1998" TYPE="STUDY">Keder 1998</LINK>, loss to follow up was 36% overall (34% in the reminder group and 38% in the no-reminder group);</LI>
<LI>
<LINK REF="STD-Casta_x00f1_o-2012" TYPE="STUDY">Castaño 2012</LINK> lost 28% from the intervention group and 30% of the control group;</LI>
<LI>In <LINK REF="STD-Kirby-2010" TYPE="STUDY">Kirby 2010</LINK>, overall loss was 25%;</LI>
<LI>
<LINK REF="STD-Gilliam-2004" TYPE="STUDY">Gilliam 2004</LINK> lost 24% overall (11% in the intervention group and 40% in the control group).</LI>
</UL>
</EXCLUSIONS>
<OTHER_BIAS_SOURCES MODIFIED="2013-08-29 09:53:43 -0400" MODIFIED_BY="[Empty name]">
<P>Four trials did not have objective outcome measures (<LINK REF="STD-Canto-De-Cetina-2001" TYPE="STUDY">Canto De Cetina 2001</LINK>; <LINK REF="STD-Gilliam-2004" TYPE="STUDY">Gilliam 2004</LINK>; <LINK REF="STD-Kirby-2010" TYPE="STUDY">Kirby 2010</LINK>; <LINK REF="STD-Casta_x00f1_o-2012" TYPE="STUDY">Castaño 2012</LINK>). <LINK REF="STD-Gilliam-2004" TYPE="STUDY">Gilliam 2004</LINK> obtained pregnancy data on only 9 of the 33 women randomized. The report provided the pregnancies by study group but not the distribution of the nine women by study group.</P>
<P>The five studies that had objective measures used a range of methods. <LINK REF="STD-Hou-2010" TYPE="STUDY">Hou 2010</LINK> assessed the number of missed pills per cycle with an electronic monitoring device. <LINK REF="STD-Berenson-2012" TYPE="STUDY">Berenson 2012</LINK> used medical records for pregnancy rates. Others assessed on-time injections <LINK REF="STD-Keder-1998" TYPE="STUDY">Keder 1998</LINK> or on-time appointments for injections (<LINK REF="STD-Trent-2013" TYPE="STUDY">Trent 2013</LINK>). The use of a biomarker to assess pill use strengthened the results of <LINK REF="STD-Jay-1984" TYPE="STUDY">Jay 1984</LINK>, given the limitations of self-reported data to measure adherence among OC users (<LINK REF="REF-Stuart-2009" TYPE="REFERENCE">Stuart 2009</LINK>). However, this objective outcome was reported as part of a scale which included self-reported missed pills. The investigators used regression to adjust for potential confounding. However, the outcomes reported (and used in this review) appeared to be crude rather than adjusted measures, meaning that the estimates were still based on randomized groups.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2013-08-14 10:48:42 -0400" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Counseling interventions</HEADING>
<P>Five trials tested counseling interventions. Three focused on use of oral contraceptives:</P>
<UL>
<LI>
<LINK REF="STD-Jay-1984" TYPE="STUDY">Jay 1984</LINK> showed the adherence scores at four months were not significantly different for the peer-counseling and nurse-counseling groups (for using oral contraceptives). The mean difference was near zero (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). These appeared to be crude results (unadjusted for other factors), although the report was not clear on this point. The losses at four months were similar for the two groups.</LI>
</UL>
<UL>
<LI>
<LINK REF="STD-Gilliam-2004" TYPE="STUDY">Gilliam 2004</LINK> did not find any significant differences between those in the multi-component intervention and the control group. The groups were not significantly different in the proportions that continued OC use at one year (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>) or those who switched the type of contraceptive used (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>). Of nine women with pregnancy data, three were from the intervention group and two were in the control group. The power to detect differences was limited since the sample size was small. Loss to follow up was lower in the intervention group (OR 0.19; 95% CI 0.03 to 1.13).</LI>
</UL>
<UL>
<LI>In <LINK REF="STD-Berenson-2012" TYPE="STUDY">Berenson 2012</LINK>, participants were assigned to special counseling about OCs plus follow-up phone calls (C+P), special clinic counseling about OC use, or usual clinic services. At 3 months, but not 12 months, the group with special counseling plus phone calls (C+P) was more likely than the special counseling group to report consistent OC use (OR 1.41; 95% CI 1.06 to 1.87) (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>). The group with counseling but no phone calls did not differ significantly from the group with standard care for any outcome. In addition, the study groups did not differ significantly for pregnancy (<LINK REF="CMP-003.03" TYPE="ANALYSIS">Analysis 3.3</LINK>).</LI>
</UL>
<P>Of the other two trials, one focused on DMPA use and one included use of DMPA, the transdermal patch, or OCs:</P>
<UL>
<LI>
<LINK REF="STD-Canto-De-Cetina-2001" TYPE="STUDY">Canto De Cetina 2001</LINK> showed a statistically significant difference in discontinuation rates between the participants who received structured counseling and those who were given routine information about DMPA. The odds ratio for discontinuation at six months was 0.36 (95% CI 0.20 to 0.64) (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>), and at 12 months the OR was 0.27 (95% CI 0.16 to 0.44) (<LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>). Women in the structured-counseling group were less likely to discontinue the method due to menstrual disturbances (amenorrhea and irregular and heavy bleeding) than women in the routine-counseling group (OR 0.20; 95% CI 0.11 to 0.37) (<LINK REF="CMP-004.03" TYPE="ANALYSIS">Analysis 4.3</LINK>). The two groups were not significantly different for discontinuation rates due to other medical problems (pregnancy, weight gain, vomiting, dizziness, depression, and loss of libido). Loss to follow up was low and similar for the two groups as well.</LI>
</UL>
<UL>
<LI>For <LINK REF="STD-Kirby-2010" TYPE="STUDY">Kirby 2010</LINK>,<I> </I>the researchers provided additional data on request. However, the original analysis involved multiple linear and logistic regression repeated measures, and included adjustments for differences between groups. The study groups were reportedly not significantly different for correct use of contraceptives (DMPA, skin patch, and OCs) (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). Self-reported pregnancy was reportedly similar for the two groups at the end of the study. The investigators provided the reported pregnancy rates by group: 27% treatment and 23% control.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Reminder interventions</HEADING>
<P>Two trials addressed use of OCs:</P>
<UL>
<LI>In <LINK REF="STD-Hou-2010" TYPE="STUDY">Hou 2010</LINK>, one group received daily text-message reminders to take their OCs. They were not significantly different from the controls for the mean number of missed pills per cycle at cycle one (<LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>) or cycle three (<LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>). These results are from the electronic monitoring device. The groups were also similar for missed pills according to the diaries. However, the mean number of missed pills ranged from 1.1 to 1.4 from the diaries and 3.5 to 5.8 from the electronic monitoring device.</LI>
</UL>
<UL>
<LI>For <LINK REF="STD-Casta_x00f1_o-2012" TYPE="STUDY">Castaño 2012</LINK>, the text-message group received daily reminders to take OCs. The messages included education about OCs benefits and instructions to avoid medication errors. Women in the text-message group were more likely than the standard-care group to still be using OCs at six months (OR 1.54; 95% CI 1.14 to 2.10) (<LINK REF="CMP-006.01" TYPE="ANALYSIS">Analysis 6.1</LINK>). The investigators also assessed OC use interruption longer than seven days. The text-message group was more likely to have avoided such an interruption (OR 1.53; 95% CI 1.13 to 2.07) (<LINK REF="CMP-006.02" TYPE="ANALYSIS">Analysis 6.2</LINK>).</LI>
</UL>
<P>Two studies addressed DMPA use:</P>
<UL>
<LI>In <LINK REF="STD-Keder-1998" TYPE="STUDY">Keder 1998</LINK>, intensive reminders were compared to the regular written appointment cards. The investigators found no significant difference in DMPA discontinuation at one year between the reminder and control groups (<LINK REF="CMP-007.01" TYPE="ANALYSIS">Analysis 7.1</LINK>). There were also no substantial differences between the two groups in on-time injections for those who continued DMPA or for the participants overall (<LINK REF="CMP-007.02" TYPE="ANALYSIS">Analysis 7.2</LINK>; <LINK REF="CMP-007.03" TYPE="ANALYSIS">Analysis 7.3</LINK>). Loss to follow up was similar for the two groups.</LI>
</UL>
<UL>
<LI>
<LINK REF="STD-Trent-2013" TYPE="STUDY">Trent 2013</LINK> provided daily text reminders for appointments, starting three days before scheduled appointment, plus monthly health messages. The conference abstract for this pilot study provided insufficient data for analysis here. Reportedly, 87% completed all three injection appointments, but fewer than half had complete adherence to schedule. Further, the abstract reported no significant difference between the groups in timeliness for the second and third injections.</LI>
</UL>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2013-10-09 11:07:44 -0400" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2013-08-13 14:54:53 -0400" MODIFIED_BY="[Empty name]">
<P>The trials on this topic provided limited evidence on whether different counseling or reminder strategies improved adherence to, or continuation of, hormonal contraceptives. Three trials showed some effect of the special intervention. They indicated improved DMPA continuation overall (<LINK REF="STD-Canto-De-Cetina-2001" TYPE="STUDY">Canto De Cetina 2001</LINK>), more OC continuation (<LINK REF="STD-Casta_x00f1_o-2012" TYPE="STUDY">Castaño 2012</LINK>), and more consistent OC use in the short-term (<LINK REF="STD-Berenson-2012" TYPE="STUDY">Berenson 2012</LINK>). The DMPA study also indicated the intervention group was less likely to discontinue due to menstrual disturbances. This suggests some benefit of counseling about contraceptive side effects, which often dominate women's decisions about family planning methods. Enhanced counseling and reminders may have some effect on contraceptive continuation, and may change the reasons why women stop using contraception.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2013-10-09 11:07:44 -0400" MODIFIED_BY="[Empty name]">
<P>The type and intensity of the experimental interventions varied across the studies. Three trials had multiple counseling contacts for each group (<LINK REF="STD-Jay-1984" TYPE="STUDY">Jay 1984</LINK>; <LINK REF="STD-Kirby-2010" TYPE="STUDY">Kirby 2010</LINK>; <LINK REF="STD-Berenson-2012" TYPE="STUDY">Berenson 2012</LINK>) as opposed to multiple components during one visit (<LINK REF="STD-Gilliam-2004" TYPE="STUDY">Gilliam 2004</LINK>). Four studies focused on reminders rather than counseling (<LINK REF="STD-Keder-1998" TYPE="STUDY">Keder 1998</LINK>; <LINK REF="STD-Hou-2010" TYPE="STUDY">Hou 2010</LINK>), of which two provided health information as well as reminders (<LINK REF="STD-Casta_x00f1_o-2012" TYPE="STUDY">Castaño 2012</LINK>; <LINK REF="STD-Trent-2013" TYPE="STUDY">Trent 2013</LINK>). The studies that showed some difference provided multiple counseling contacts for the special intervention group (<LINK REF="STD-Canto-De-Cetina-2001" TYPE="STUDY">Canto De Cetina 2001</LINK>; <LINK REF="STD-Berenson-2012" TYPE="STUDY">Berenson 2012</LINK>) or multiple reminders and health information (<LINK REF="STD-Casta_x00f1_o-2012" TYPE="STUDY">Castaño 2012</LINK>). The nature as well as the intensity of the intervention may be associated with successful use of contraception.</P>
<P>The studies primarily addressed OCs and DMPA; one also included the transdermal patch. None examined counseling for users of the vaginal ring, an implant, an IUD, or the LNG IUS. The ring requires user action similar to that for the patch. Counseling about correct use and providing reminders could reduce errors and discontinuation rates. For long-acting methods such as implants and intrauterine systems, women could benefit from appropriate counseling about side effects and the importance of continuation. </P>
<P>Eight studies were conducted in the USA, and most were in urban clinics or family planning centers. One took place in Mexico. Six focused on adolescents or young women up to 25 years old. The external validity may be a limiting factor for this review. The individual study findings may be specific to the setting. While all were initiated within clinics, many provided outreach during the follow-up period by telephone or text message. The content and process of counseling or reminder interventions may be appropriate for a local population or clinic and not relevant universally, so effects may differ across groups and sites.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2013-08-27 10:23:23 -0400" MODIFIED_BY="[Empty name]">
<P>We assessed the quality of evidence using GRADE principles (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). The level was based primarily on study design; downgrading was based on information regarding randomization sequence generation and allocation concealment, losses to follow up, outcomes being self-reported, or the intervention provided reminders only. We summarized the trial results and quality assessment (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>). The overall quality of evidence for this review was considered moderate. While one pilot study had high-quality evidence, the information from the abstract was limited. The evidence was moderate quality for four trials and low for the remaining four.</P>
<P>Ascertainment bias may have arisen in two ways. First, assessment of subjective outcomes may have been influenced by the lack of treatment blinding. If present, however, it did not produce favorable results. In addition, self-reported data has limited value for measuring continuation and consistency of contraceptive use due to social desirability bias (<LINK REF="REF-Stuart-2009" TYPE="REFERENCE">Stuart 2009</LINK>). Six studies also used some objective measure, i.e., pregnancy, urinary riboflavin in an adherence scale, on-time injections or appointments, and an electronic monitoring device.</P>
<P>This review has limitations that warrant cautious interpretation of the results. Six studies had high losses to follow up. After randomization, losses to follow up that exceed 20% can jeopardize trial validity (<LINK REF="REF-Strauss-2005" TYPE="REFERENCE">Strauss 2005</LINK>). Three trials and one pilot study had small sample sizes (<LINK REF="STD-Jay-1984" TYPE="STUDY">Jay 1984</LINK>; <LINK REF="STD-Gilliam-2004" TYPE="STUDY">Gilliam 2004</LINK>; <LINK REF="STD-Hou-2010" TYPE="STUDY">Hou 2010</LINK>; <LINK REF="STD-Trent-2013" TYPE="STUDY">Trent 2013</LINK>), which increased the likelihood of a Type II error.</P>
<P>Most trials included in this review randomized participants within the center. This method can lead to some 'contamination' across study groups, due to participants sharing information. Such sharing would reduce the likelihood of finding a difference between the groups.</P>
</QUALITY_OF_EVIDENCE>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2013-10-09 11:16:50 -0400" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2013-10-09 11:16:50 -0400" MODIFIED_BY="[Empty name]">
<P>Good personal communication between clients and providers is generally considered important for successful use of hormonal contraception. Some evidence from randomized controlled trials indicates that use of oral contraceptives and injectables can be improved with enhanced counseling or intensive reminders plus health information. Therefore, a combination of intensive counseling and multiple contacts and reminders may help improve adherence to, and acceptability of, these contraceptive methods.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2013-10-09 11:10:58 -0400" MODIFIED_BY="[Empty name]">
<P>The published trials provided moderate quality evidence for our purposes. Several had small sample sizes and most had high losses to follow up. Four trials did not have objective outcome measures; self-reports have unknown validity. No eligible trial examined use of the vaginal ring, an implant, or an intrauterine system. High-quality RCTs with adequate power and well-designed interventions could help identify ways to improve adherence to, and continuation of, hormonal contraceptive methods. A trial with randomization at the clinic level or a non-randomized multi-site comparative study may provide additional information. </P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2013-08-07 15:02:01 -0400" MODIFIED_BY="[Empty name]">
<P>Carol Manion of FHI 360 assisted with literature searches.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2010-10-06 16:25:43 -0400" MODIFIED_BY="[Empty name]">
<P>DA Grimes has consulted with the pharmaceutical companies Bayer Healthcare Pharmaceuticals and Merck &amp; Co, Inc.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2013-08-13 15:09:33 -0400" MODIFIED_BY="[Empty name]">
<P>V Halpern developed the idea, did the primary data extraction for the initial review and drafted the review. For the initial review, LM Lopez did the secondary data extraction and wrote part of the review. For the updates (2008 to 2013), LM Lopez reviewed the search results, extracted data, and revised the review. DA Grimes participated in writing the initial review, and did the secondary data extraction for two updates (2008 and 2010). In 2013, LL Stockton extracted data and checked data entry. MF Gallo provided assistance with data extraction for the initial review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2013-10-09 10:41:29 -0400" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2013-07-30 16:05:17 -0400" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2013-07-30 16:05:17 -0400" MODIFIED_BY="Laureen M Lopez">
<STUDY DATA_SOURCE="PUB" ID="STD-Berenson-2012" MODIFIED="2013-07-08 16:12:06 -0400" MODIFIED_BY="[Empty name]" NAME="Berenson 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-07-08 16:12:06 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;A randomized controlled study of two educational interventions on adherence with oral contraceptives and condoms&lt;/p&gt;" NOTES_MODIFIED="2013-07-08 16:12:06 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Berenson A B, Rahman M</AU>
<TI>A randomized controlled study of two educational interventions on adherence with oral contraceptives and condoms</TI>
<SO>Contraception</SO>
<YR>2012</YR>
<VL>86</VL>
<NO>6</NO>
<PG>716-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-07-08 16:12:06 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Berenson AB</AU>
<TI>Improving Adolescent Adherence to Hormonal Contraception</TI>
<SO>http://clinicaltrials.gov/ct2/show/NCT00584038</SO>
<YR>(accessed 29 Oct 2010)</YR>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="NCT00584038"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Canto-De-Cetina-2001" MODIFIED="2011-01-11 14:44:38 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Canto De Cetina 2001" YEAR="">
<REFERENCE MODIFIED="2011-01-11 14:44:38 -0500" MODIFIED_BY="Laureen M Lopez" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Canto De Cetina TE, Canto P, Luna MO</AU>
<TI>Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate</TI>
<SO>Contraception</SO>
<YR>2001</YR>
<VL>63</VL>
<NO>3</NO>
<PG>143-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Casta_x00f1_o-2012" MODIFIED="2013-07-30 16:05:17 -0400" MODIFIED_BY="[Empty name]" NAME="Castaño 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-07-30 16:05:17 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't&lt;/p&gt;" NOTES_MODIFIED="2013-07-30 16:05:17 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Castaño PM, Bynum JY, Andrés R, Lara M, Westhoff C</AU>
<TI>Effect of daily text messages on oral contraceptive continuation: a randomized controlled trial</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2012</YR>
<VL>119</VL>
<NO>1</NO>
<PG>14-20</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="NCT00677703"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-07-29 15:31:03 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Hall, Kelli Stidham&lt;br&gt;Westhoff, Carolyn L&lt;br&gt;Castano, Paula M&lt;br&gt;1 F31 NR011119-01A1/NR/NINR NIH HHS/&lt;br&gt;2R24HD047879/HD/NICHD NIH HHS/&lt;br&gt;K12HD001438/HD/NICHD NIH HHS/&lt;br&gt;Contraception. 2013 Apr;87(4):449-54. doi: 10.1016/j.contraception.2012.09.004. Epub 2012 Oct 10.&lt;/p&gt;" NOTES_MODIFIED="2013-07-29 15:31:03 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hall KS, Westhoff CL, Castaño PM</AU>
<TI>The impact of an educational text message intervention on young urban women's knowledge of oral contraception</TI>
<SO>Contraception</SO>
<YR>2013</YR>
<VL>87</VL>
<NO>4</NO>
<PG>449-54</PG>
<EN>2012/10/16</EN>
<MD>Research Support, N.I.H., Extramural</MD>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gilliam-2004" MODIFIED="2011-01-11 14:44:42 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Gilliam 2004" YEAR="2004">
<REFERENCE MODIFIED="2011-01-11 14:44:42 -0500" MODIFIED_BY="Laureen M Lopez" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gilliam M, Knight S, McCarthy M</AU>
<TI>Success with oral contraceptives: a pilot study</TI>
<SO>Contraception</SO>
<YR>2004</YR>
<VL>69</VL>
<NO>5</NO>
<PG>413-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hou-2010" MODIFIED="2010-12-20 15:49:21 -0500" MODIFIED_BY="[Empty name]" NAME="Hou 2010" YEAR="2010">
<REFERENCE MODIFIED="2010-12-20 15:49:21 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hou MY, Hurwitz S, Kavanagh E, Fortin J, Goldberg AB</AU>
<TI>Using daily text-message reminders to improve adherence with oral contraceptives</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2010</YR>
<VL>116</VL>
<NO>3</NO>
<PG>633-40</PG>
<IDENTIFIERS MODIFIED="2010-12-20 15:49:21 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-12-20 15:49:21 -0500" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="NCT00733707"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jay-1984" MODIFIED="2011-01-11 14:44:47 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Jay 1984" YEAR="">
<REFERENCE MODIFIED="2011-01-11 14:44:47 -0500" MODIFIED_BY="Laureen M Lopez" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jay MS, DuRant RH, Shoffitt T, Linder CW, Litt IF</AU>
<TI>Effect of peer counselors on adolescent compliance in use of oral contraceptives</TI>
<SO>Pediatrics</SO>
<YR>1984</YR>
<VL>73</VL>
<NO>2</NO>
<PG>126-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Keder-1998" MODIFIED="2011-01-11 14:44:33 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Keder 1998" YEAR="">
<REFERENCE MODIFIED="2011-01-11 14:44:33 -0500" MODIFIED_BY="Laureen M Lopez" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Keder LM, Rulin MC, Gruss J</AU>
<TI>Compliance with depot medroxyprogesterone acetate: a randomized, controlled trial of intensive reminders</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1998</YR>
<VL>179</VL>
<NO>3 Pt 1</NO>
<PG>583-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kirby-2010" MODIFIED="2011-01-03 13:55:48 -0500" MODIFIED_BY="[Empty name]" NAME="Kirby 2010" YEAR="2008">
<REFERENCE MODIFIED="2011-01-03 13:55:48 -0500" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kirby D, Raine T, Thrush G, Yuen C, Sokoloff A, Potter SC</AU>
<TI>Impact of an intervention to improve contraceptive use through follow-up phone calls to female adolescent clinic patients</TI>
<SO>Perspectives on Sexual and Reproductive Health</SO>
<YR>2010</YR>
<VL>42</VL>
<NO>4</NO>
<PG>251-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="NCT00230880"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-12-20 15:37:38 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Raine TR</AU>
<TI>Young Woman's Reach Project: Trial of an Intervention to Impact Contraceptive Behavior, Unintended Pregnancy, and Sexually Transmitted Infections (STIs) Among Adolescent Females (REACH)</TI>
<SO>http://clinicaltrials.gov/ct2/show/NCT00230880</SO>
<YR>(accessed 10 Dec 2010)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Trent-2013" MODIFIED="2013-07-30 13:34:53 -0400" MODIFIED_BY="[Empty name]" NAME="Trent 2013" YEAR="2013">
<REFERENCE MODIFIED="2013-07-16 12:44:53 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Trent M, Tomaszewski K</AU>
<TI>Family planning appointment attendance among urban youth: Results from the depotext trial</TI>
<SO>Journal of Adolescent Health</SO>
<YR>2013</YR>
<VL>52</VL>
<NO>2</NO>
<PG>S88</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-07-16 12:44:53 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Trent M</AU>
<TI>Meaningful use of technology to improve health care delivery</TI>
<SO>http://clinicaltrials.gov/ct2/show/NCT01641380</SO>
<YR>(accessed 11 Jul 2013)</YR>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="NCT01641380"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2013-07-23 15:27:45 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="MIX" ID="STD-Andolsek-1982" MODIFIED="2013-07-23 11:47:26 -0400" MODIFIED_BY="[Empty name]" NAME="Andolsek 1982" YEAR="1982">
<REFERENCE MODIFIED="2013-07-23 11:47:26 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Andolsek L, Pretnar A</AU>
<TI>Influence of counseling in postabortal contraception</TI>
<SO>Presented at Reproductive Health Care International Symposium; 1982 Oct 10-15; Maui, Hawaii</SO>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Behboodi-2013" MODIFIED="2013-07-22 11:35:05 -0400" MODIFIED_BY="[Empty name]" NAME="Behboodi 2013" YEAR="2013">
<REFERENCE MODIFIED="2013-07-22 11:35:05 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Behboodi Z</AU>
<TI>The effect of an educational program based on BASNEF model on choosing contraceptive methods in women</TI>
<SO>http://www.irct.ir/searchresult.php?id=9463&amp;number=2</SO>
<YR>(accessed 11 Jul 2013)</YR>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="IRCT201205289463N2"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bender-2004" MODIFIED="2011-01-11 14:49:46 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Bender 2004" YEAR="2004">
<REFERENCE MODIFIED="2011-01-11 14:49:46 -0500" MODIFIED_BY="Laureen M Lopez" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bender SS, Geirsson RT</AU>
<TI>Effectiveness of preabortion counseling on postabortion contraceptive use</TI>
<SO>Contraception</SO>
<YR>2004</YR>
<VL>69</VL>
<NO>6</NO>
<PG>481-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Burnhill-1985" MODIFIED="2013-07-23 15:27:45 -0400" MODIFIED_BY="[Empty name]" NAME="Burnhill 1985" YEAR="1985">
<REFERENCE MODIFIED="2013-07-23 15:27:45 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Burnhill MS, King E, Koteen E</AU>
<TI>Impact of counseling on repeated unplanned pregnancy and contraceptive behavior in low SES abortion population</TI>
<SO>New Brunswick (NJ): Department of Obstetrics and Gynecology, UMDNJ - Rutgers Medical School</SO>
<YR>1985</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carneiro-2011" MODIFIED="2013-07-10 14:37:47 -0400" MODIFIED_BY="[Empty name]" NAME="Carneiro 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-07-10 14:37:47 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Journal Article; Randomized Controlled Trial&lt;/p&gt;" NOTES_MODIFIED="2013-07-10 14:37:47 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="OTHER">
<AU>Carneiro Gomes Ferreira AL, Impieri Souza A, Evangelista Pessoa R, Braga C</AU>
<TI>The effectiveness of contraceptive counseling for women in the postabortion period: an intervention study</TI>
<SO>Contraception</SO>
<YR>2011</YR>
<NO>4</NO>
<PG>377-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-07-10 14:37:44 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Ferreiro AL</AU>
<TI>Contraceptive Counseling Following an Abortion (APA)</TI>
<SO>http://clinicaltrials.gov/ct2/show/study/NCT00756314</SO>
<YR>(accessed 29 Oct 2010)</YR>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="NCT00756314"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gilliam-2010" MODIFIED="2013-07-08 14:07:22 -0400" MODIFIED_BY="[Empty name]" NAME="Gilliam 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-07-08 14:07:22 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;MarAdherence and acceptability of the contraceptive ring compared with the pill among students: a randomized controlled trialGilliam, Melissa L&lt;br&gt;Neustadt, Amy&lt;br&gt;Kozloski, Michael&lt;br&gt;Mistretta, Stephanie&lt;br&gt;Tilmon, Sandra&lt;br&gt;Godfrey, Emily&lt;br&gt;Multicenter Study&lt;br&gt;Randomized Controlled Trial&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;United States&lt;br&gt;Obstetrics and gynecology&lt;br&gt;Obstet Gynecol. 2010 Mar;115(3):503-10.NLM&lt;/p&gt;" NOTES_MODIFIED="2013-07-08 14:07:22 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gilliam M L, Neustadt A, Kozloski M, Mistretta S, Tilmon S, Godfrey E</AU>
<TI>Adherence and acceptability of the contraceptive ring compared with the pill among students: a randomized controlled trial</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2010</YR>
<VL>115</VL>
<NO>3</NO>
<PG>503-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-07-08 14:07:22 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;OctDaily context matters: predictors of missed oral contraceptive pills among college and graduate studentsHughey, Andrew B&lt;br&gt;Neustadt, Amy B&lt;br&gt;Mistretta, Stephanie Q&lt;br&gt;Tilmon, Sandra J&lt;br&gt;Gilliam, Melissa L&lt;br&gt;Randomized Controlled Trial&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;United States&lt;br&gt;American journal of obstetrics and gynecology&lt;br&gt;Am J Obstet Gynecol. 2010 Oct;203(4):323.e1-7.NLM&lt;/p&gt;" NOTES_MODIFIED="2013-07-08 14:07:22 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hughey A B, Neustadt A B, Mistretta S Q, Tilmon S J, Gilliam M L</AU>
<TI>Daily context matters: predictors of missed oral contraceptive pills among college and graduate students</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2010</YR>
<VL>203</VL>
<NO>4</NO>
<PG>323 e1-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Langston-2010" MODIFIED="2013-07-08 14:37:01 -0400" MODIFIED_BY="[Empty name]" NAME="Langston 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-07-08 14:31:40 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Langston, Aileen M&lt;br&gt;Rosario, Linette&lt;br&gt;Westhoff, Carolyn L&lt;br&gt;Randomized Controlled Trial&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;Ireland&lt;br&gt;Patient Educ Couns. 2010 Dec;81(3):362-7.&lt;/p&gt;" NOTES_MODIFIED="2013-07-08 14:31:40 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="OTHER">
<AU>Langston AM, Rosario L, Westhoff CL</AU>
<TI>Structured contraceptive counseling--a randomized controlled trial</TI>
<SO>Patient Education and Counseling</SO>
<YR>2010</YR>
<VL>81</VL>
<NO>3</NO>
<PG>362-7</PG>
<EN>2010/09/28</EN>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-07-08 14:31:40 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Langston AM, Rosario LY, Westhoff CL</AU>
<TI>Structured contraceptive counseling: a randomized controlled trial [abstract]</TI>
<SO>Contraception</SO>
<YR>2010</YR>
<VL>82</VL>
<NO>2</NO>
<PG>188-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-07-08 14:37:01 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Westhoff C</AU>
<TI>Randomized controlled trial of structured contraceptive counseling in adult women</TI>
<SO>http://clinicaltrials.gov/ct2/show/NCT00746993</SO>
<YR>(accessed 08 Jul 2013)</YR>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="NCT00746993"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-07-08 14:31:40 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>World Health Organization</AU>
<TI>Decision-making tool for family planning clients and providers</TI>
<SO>http://www.who.int/reproductivehealth/publications/family_planning/9241593229index/en/index.html</SO>
<YR>(accessed 08 Jan 2012)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Madden-2013" MODIFIED="2013-07-22 11:13:46 -0400" MODIFIED_BY="[Empty name]" NAME="Madden 2013" YEAR="2013">
<REFERENCE MODIFIED="2013-07-22 11:13:46 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Madden T, Mullersman JL, Omvig KJ, Secura GM, Peipert JF</AU>
<TI>Structured contraceptive counseling provided by the Contraceptive CHOICE Project</TI>
<SO>Contraception</SO>
<YR>88</YR>
<VL>2</VL>
<PG>243-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Metson-1991" MODIFIED="2011-01-12 10:28:46 -0500" MODIFIED_BY="[Empty name]" NAME="Metson 1991" YEAR="1991">
<REFERENCE MODIFIED="2011-01-12 10:28:46 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Metson D, Kassianos GC, Norman DP, Moriarty JMA</AU>
<TI>Effect of information leaflets on long term recall - useful or useless?</TI>
<SO>British Journal of Family Planning</SO>
<YR>1991</YR>
<VL>17</VL>
<NO>1</NO>
<PG>21-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roye-2007" MODIFIED="2011-01-11 14:47:00 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Roye 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-01-11 14:46:49 -0500" MODIFIED_BY="Laureen M Lopez" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Roye C, Perlmutter Silverman P, Krauss B</AU>
<TI>A brief, low-cost, theory-based intervention to promote dual method use by black and Latina female adolescents: a randomized clinical trial</TI>
<SO>Health Education &amp; Behavior</SO>
<YR>2007</YR>
<VL>34</VL>
<NO>4</NO>
<PG>608-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-01-11 14:47:00 -0500" MODIFIED_BY="Laureen M Lopez" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roye CF, Hudson M</AU>
<TI>Developing a culturally appropriate video to promote dual-method use by urban teens: rationale and methodology</TI>
<SO>AIDS Education and Prevention</SO>
<YR>2003</YR>
<VL>15</VL>
<NO>2</NO>
<PG>148-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schunmann-2006" MODIFIED="2011-01-11 14:54:39 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Schunmann 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-01-11 14:54:39 -0500" MODIFIED_BY="Laureen M Lopez" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schunmann C, Glasier A</AU>
<TI>Specialist contraceptive counselling and provision after termination of pregnancy improves uptake of long-acting methods but does not prevent repeat abortion: a randomized trial</TI>
<SO>Human Reproduction</SO>
<YR>2006</YR>
<VL>21</VL>
<NO>9</NO>
<PG>2296-303</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schwandt-2013" MODIFIED="2013-07-22 11:09:59 -0400" MODIFIED_BY="[Empty name]" NAME="Schwandt 2013" YEAR="2013">
<REFERENCE MODIFIED="2013-07-22 11:09:59 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Schwandt, Hilary M&lt;br&gt;Creanga, Andreea A&lt;br&gt;Danso, Kwabena A&lt;br&gt;Adanu, Richard M K&lt;br&gt;Agbenyega, Tsiri&lt;br&gt;Hindin, Michelle J&lt;br&gt;Contraception. 2013 Mar 22. pii: S0010-7824(13)00094-2. doi: 10.1016/j.contraception.2013.03.008.&lt;/p&gt;" NOTES_MODIFIED="2013-07-22 11:09:59 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schwandt HM, Creanga AA, Danso KA, Adanu RM, Agbenyega T, Hindin MJ</AU>
<TI>Group versus individual family planning counseling in Ghana: a randomized, noninferiority trial</TI>
<SO>Contraception</SO>
<YR>2013</YR>
<VL>88</VL>
<NO>2</NO>
<PG>281-8</PG>
<EN>2013/05/07</EN>
<IDENTIFIERS MODIFIED="2013-07-22 11:09:14 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schwarz-2008" MODIFIED="2010-10-29 09:03:49 -0400" MODIFIED_BY="Laureen M Lopez" NAME="Schwarz 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-10-29 09:03:37 -0400" MODIFIED_BY="Laureen M Lopez" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schwarz EB, Gerbert B, Gonzales R</AU>
<TI>Computer-assisted provision of emergency contraception a randomized controlled trial</TI>
<SO>Journal of General Internal Medicine</SO>
<YR>2008</YR>
<VL>23</VL>
<NO>6</NO>
<PG>794-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Westhoff-2010" MODIFIED="2010-10-14 16:07:39 -0400" MODIFIED_BY="[Empty name]" NAME="Westhoff 2010" YEAR="2010">
<REFERENCE MODIFIED="2010-10-14 16:07:10 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Langston AM, Rosario LY, Westhoff CL</AU>
<TI>Structured contraceptive counseling: a randomized controlled trial [abstract]</TI>
<SO>Contraception</SO>
<YR>2010</YR>
<VL>82</VL>
<NO>2</NO>
<PG>188-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-10-14 16:07:39 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="OTHER">
<AU>Westhoff C</AU>
<TI>Randomized Controlled Trial of Structured Contraceptive Counseling in Adult Women</TI>
<SO>http://clinicaltrials.gov/ct2/show/NCT00746993</SO>
<YR>(accessed 14 Oct 2010)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2010-10-14 16:00:24 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-10-14 16:00:24 -0400" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00746993"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhu-2009" MODIFIED="2010-10-29 10:51:56 -0400" MODIFIED_BY="Laureen M Lopez" NAME="Zhu 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-10-29 10:51:56 -0400" MODIFIED_BY="Laureen M Lopez" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhu JL, Zhang W-H, Cheng Y, Xu J, Xu X, Gibson D, et al</AU>
<TI>Impact of post-abortion family planning services on contraceptive use and abortion rate among young women in China: a cluster randomised trial</TI>
<SO>European Journal of Contraception and Reproductive Health Care</SO>
<YR>2009</YR>
<VL>14</VL>
<NO>1</NO>
<PG>46-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2013-07-16 12:44:53 -0400" MODIFIED_BY="Laureen M Lopez"/>
<ONGOING_STUDIES MODIFIED="2013-07-30 13:37:19 -0400" MODIFIED_BY="Laureen M Lopez">
<STUDY DATA_SOURCE="PUB" ID="STD-Smith-2013" MODIFIED="2013-07-30 13:10:07 -0400" MODIFIED_BY="[Empty name]" NAME="Smith 2013" YEAR="2013">
<REFERENCE MODIFIED="2013-07-30 13:09:37 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Smith CGJ</AU>
<TI>Mobile technology for improved family planning</TI>
<SO>http://clinicaltrials.gov/ct2/NCT01823861</SO>
<YR>(accessed 11 Jul 2013)</YR>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="NCT01823861"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-07-30 13:10:14 -0400" MODIFIED_BY="[Empty name]"/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2013-10-09 10:41:29 -0400" MODIFIED_BY="Laureen M Lopez">
<ADDITIONAL_REFERENCES MODIFIED="2013-10-09 10:41:29 -0400" MODIFIED_BY="Laureen M Lopez">
<REFERENCE ID="REF-ARHP-2004" NAME="ARHP 2004" TYPE="OTHER">
<AU>Association of Reproductive Health Professionals</AU>
<TI>Periodic well-woman visit: individualized contraceptive care</TI>
<SO>ARHP Clinical Proceedings</SO>
<YR>2004</YR>
<VL>May</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bartz-2011" MODIFIED="2013-10-09 10:41:29 -0400" MODIFIED_BY="[Empty name]" NAME="Bartz 2011" TYPE="BOOK_SECTION">
<AU>Bartz D, Goldberg AB</AU>
<TI>Injectable contraceptives</TI>
<SO>Contraceptive Technology</SO>
<YR>2011</YR>
<PG>209-36</PG>
<EN>20th revised</EN>
<ED>Hatcher RA, Trussell J, Nelson AL, Cates W, Kowal D, Pollicar MS</ED>
<PB>Ardent Media, Inc.</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Blanc-2002" MODIFIED="2011-01-11 14:55:36 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Blanc 2002" TYPE="JOURNAL_ARTICLE">
<AU>Blanc AK, Curtis SL, Croft TN</AU>
<TI>Monitoring contraceptive continuation: links to fertility outcomes and quality of care</TI>
<SO>Studies in Family Planning</SO>
<YR>2002</YR>
<VL>33</VL>
<NO>2</NO>
<PG>127-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Davie-1996" MODIFIED="2011-01-11 14:56:07 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Davie 1996" TYPE="JOURNAL_ARTICLE">
<AU>Davie JE, Walling MR, Mansour DJ, Bromham D, Kishen M, Fowler P</AU>
<TI>Impact of patient counseling on acceptance of the levonorgestrel implant contraceptive in the United Kingdom</TI>
<SO>Clinical Therapy</SO>
<YR>1996</YR>
<VL>18</VL>
<NO>1</NO>
<PG>150-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Diaz-2000" MODIFIED="2011-01-11 14:56:58 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Diaz 2000" TYPE="JOURNAL_ARTICLE">
<AU>Diaz J, Bahamondes L, Monteiro I, Petta C, Hildalgo MM, Arce XE</AU>
<TI>Acceptability and performance of the levonorgestrel-releasing intrauterine system (Mirena) in Campinas, Brazil</TI>
<SO>Contraception</SO>
<YR>2000</YR>
<VL>62</VL>
<NO>2</NO>
<PG>59-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dieben-2002" MODIFIED="2011-01-11 14:57:30 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Dieben 2002" TYPE="JOURNAL_ARTICLE">
<AU>Dieben TO, Roumen FJ, Apter D</AU>
<TI>Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2002</YR>
<VL>100</VL>
<NO>3</NO>
<PG>585-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fleming-1998" MODIFIED="2011-01-11 14:59:08 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Fleming 1998" TYPE="JOURNAL_ARTICLE">
<AU>Fleming D, Davie J, Glasier A</AU>
<TI>Continuation rates of long-acting methods of contraception. A comparative study of Norplant implants and intrauterine devices</TI>
<SO>Contraception</SO>
<YR>1998</YR>
<VL>57</VL>
<NO>1</NO>
<PG>19-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gallo-2013" MODIFIED="2013-08-14 14:52:09 -0400" MODIFIED_BY="Laureen M Lopez" NAME="Gallo 2013" TYPE="COCHRANE_REVIEW">
<AU>Gallo MF, Nanda K, Grimes DA, Lopez LM, Schulz KF</AU>
<TI>20 µg versus &gt;20 µg estrogen combined oral contraceptives for contraception</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>8</NO>
<IDENTIFIERS MODIFIED="2013-07-29 09:06:26 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-07-29 09:06:26 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003989.pub5"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Gaudet-2004" MODIFIED="2011-01-11 15:01:11 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Gaudet 2004" TYPE="JOURNAL_ARTICLE">
<AU>Gaudet LM, Kives S, Hahn PM, Reid RL</AU>
<TI>What women believe about oral contraceptives and the effect of counseling</TI>
<SO>Contraception</SO>
<YR>2004</YR>
<VL>69</VL>
<NO>1</NO>
<PG>31-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Glasier-2002" MODIFIED="2011-01-11 15:02:29 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Glasier 2002" TYPE="JOURNAL_ARTICLE">
<AU>Glasier A</AU>
<TI>Implantable contraceptives for women: effectiveness, discontinuation rates, return of fertility, and outcome of pregnancies</TI>
<SO>Contraception</SO>
<YR>2002</YR>
<VL>65</VL>
<NO>1</NO>
<PG>29-37</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hall-1997" MODIFIED="2011-01-11 15:03:19 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Hall 1997" TYPE="JOURNAL_ARTICLE">
<AU>Hall P, Bahamondes L, Diaz J, Petta C</AU>
<TI>Introductory study of the once-a-month, injectable contraceptive Cyclofem in Brazil, Chile, Colombia, and Peru</TI>
<SO>Contraception</SO>
<YR>1997</YR>
<VL>56</VL>
<NO>6</NO>
<PG>353-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2013-07-08 09:45:39 -0400" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<YR>(accessed 24 October 2012)</YR>
<PB>John Wiley &amp; Sons, Ltd</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jain-1989" MODIFIED="2011-01-11 15:04:05 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Jain 1989" TYPE="JOURNAL_ARTICLE">
<AU>Jain AK</AU>
<TI>Fertility reduction and the quality of family planning services</TI>
<SO>Studies in Family Planning</SO>
<YR>1989</YR>
<VL>20</VL>
<NO>1</NO>
<PG>1-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jones-2012" MODIFIED="2013-08-29 09:13:17 -0400" MODIFIED_BY="[Empty name]" NAME="Jones 2012" TYPE="BOOK">
<AU>Jones J, Mosher W, Daniels K</AU>
<TI>Current contraceptive use in the United States, 2006-2012, and changes in patterns of use since 1995</TI>
<SO>National health statistics reports; no 60</SO>
<YR>2012</YR>
<PB>National Center for Health Statistics</PB>
<CY>Hyattsville, MD (USA)</CY>
<IDENTIFIERS MODIFIED="2013-08-29 09:13:17 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Lei-1996" MODIFIED="2011-01-11 15:04:28 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Lei 1996" TYPE="JOURNAL_ARTICLE">
<AU>Lei ZW, Wu SC, Garceau RJ, Jiang S, Yang QZ, Wang WL, et al</AU>
<TI>Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception</TI>
<SO>Contraception</SO>
<YR>1996</YR>
<VL>53</VL>
<NO>6</NO>
<PG>357-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Leite-2007" NAME="Leite 2007" TYPE="JOURNAL_ARTICLE">
<AU>Leite IC, Gupta N</AU>
<TI>Assessing regional differences in contraceptive discontinuation, failure and switching in Brazil</TI>
<SO>Reproductive Health</SO>
<YR>2007</YR>
<VL>4</VL>
<PG>6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Little-1998" MODIFIED="2011-01-11 15:06:06 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Little 1998" TYPE="JOURNAL_ARTICLE">
<AU>Little P, Griffin S, Kelly J, Dickson N, Sadler C</AU>
<TI>Effect of educational leaflets and questions on knowledge of contraception in women taking the combined contraceptive pill: randomised controlled trial</TI>
<SO>British Medical Journal</SO>
<YR>1998</YR>
<VL>316</VL>
<NO>7149</NO>
<PG>1948-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Murphy-2008" MODIFIED="2011-01-11 15:06:46 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Murphy 2008" TYPE="JOURNAL_ARTICLE">
<AU>Murphy PA, Brixner D</AU>
<TI>Hormonal contraceptive discontinuation patterns according to formulation: investigation of associations in an administrative claims database</TI>
<SO>Contraception</SO>
<YR>2008</YR>
<VL>77</VL>
<NO>4</NO>
<PG>257-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NCCWCH-2005" MODIFIED="2013-10-08 16:31:26 -0400" MODIFIED_BY="[Empty name]" NAME="NCCWCH 2005" TYPE="BOOK">
<AU>National Collaborating Centre for Women&#8217;s and Children&#8217;s Health</AU>
<SO>Long-acting Reversible Contraception: The Effective and Appropriate Use of Long-Acting Reversible Contraception</SO>
<YR>2005. (NICE Clinical Guidelines, No. 30)</YR>
<PB>RCOG Press</PB>
<CY>London</CY>
<IDENTIFIERS MODIFIED="2013-10-08 16:31:26 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-10-08 16:31:26 -0400" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="http://www.ncbi.nlm.nih.gov/books/NBK51051/"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Nelson-2008" MODIFIED="2013-08-14 14:58:54 -0400" MODIFIED_BY="[Empty name]" NAME="Nelson 2008" NOTES="&lt;p&gt;Nelson, Anita L&lt;br&gt;Westhoff, Carolyn&lt;br&gt;Schnare, Sharon Myoji&lt;br&gt;eng&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;2008/10/02 09:00&lt;br&gt;Obstet Gynecol. 2008 Oct;112(4):782-7. doi: 10.1097/AOG.0b013e3181875ec5.&lt;/p&gt;" NOTES_MODIFIED="2013-08-14 14:58:54 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Nelson AL, Westhoff C, Schnare SM</AU>
<TI>Real-world patterns of prescription refills for branded hormonal contraceptives: a reflection of contraceptive discontinuation</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2008</YR>
<VL>112</VL>
<NO>4</NO>
<PG>782-7</PG>
<IDENTIFIERS MODIFIED="2013-08-14 14:58:54 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Robinson-2002" MODIFIED="2011-01-11 15:07:59 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Robinson 2002" TYPE="JOURNAL_ARTICLE">
<AU>Robinson KA, Dickersin K</AU>
<TI>Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed</TI>
<SO>International Journal of Epidemiology</SO>
<YR>2002</YR>
<VL>31</VL>
<NO>1</NO>
<PG>150-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rosenberg-1995" MODIFIED="2011-01-11 15:08:29 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Rosenberg 1995" TYPE="JOURNAL_ARTICLE">
<AU>Rosenberg MJ, Waugh MS, Long S</AU>
<TI>Unintended pregnancies and use, misuse, and discontinuation of oral contraceptives</TI>
<SO>Journal of Reproductive Medicine</SO>
<YR>1995</YR>
<VL>40</VL>
<NO>5</NO>
<PG>355-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rosenberg-1998" MODIFIED="2011-01-11 15:09:13 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Rosenberg 1998" TYPE="JOURNAL_ARTICLE">
<AU>Rosenberg MJ, Waugh MS, Burnhill MS</AU>
<TI>Compliance, counseling and satisfaction with oral contraceptives: a prospective evaluation</TI>
<SO>Family Planning Perspectives</SO>
<YR>1998</YR>
<VL>30</VL>
<NO>2</NO>
<PG>89-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rosenberg-1999" MODIFIED="2011-01-11 15:09:37 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Rosenberg 1999" TYPE="JOURNAL_ARTICLE">
<AU>Rosenberg MJ, Waugh MS</AU>
<TI>Causes and consequences of oral contraceptive noncompliance</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1999</YR>
<VL>180</VL>
<NO>Suppl 2</NO>
<PG>276-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rudy-2003" NAME="Rudy 2003" TYPE="OTHER">
<AU>Rudy S, Tabbutt-Henry J, Schaefer L, McQuide P</AU>
<TI>Improving client-provider interaction</TI>
<SO>Population Reports</SO>
<YR>2003</YR>
<VL>Series Q</VL>
<NO>1</NO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Silberstein-1966" MODIFIED="2011-01-11 15:11:30 -0500" MODIFIED_BY="Laureen M Lopez" NAME="Silberstein 1966" TYPE="JOURNAL_ARTICLE">
<AU>Silberstein RM, Blackman S</AU>
<TI>A method to evaluate whether patients take prescribed medication</TI>
<SO>Clinical Pediatrics</SO>
<YR>1966</YR>
<VL>5</VL>
<NO>4</NO>
<PG>239-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Strauss-2005" MODIFIED="2011-01-06 15:52:51 -0500" MODIFIED_BY="[Empty name]" NAME="Strauss 2005" TYPE="BOOK">
<AU>Strauss SE, Richardson WS, Glasziou P, Haynes RB</AU>
<SO>Evidence-based Medicine: How to Practice and Teach EBM</SO>
<YR>2005</YR>
<EN>Third</EN>
<PB>Churchill Livingstone</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stuart-2009" MODIFIED="2013-08-27 10:06:08 -0400" MODIFIED_BY="[Empty name]" NAME="Stuart 2009" TYPE="JOURNAL_ARTICLE">
<AU>Stuart GS, Grimes DA</AU>
<TI>Social desirability bias in family planning studies: a neglected problem</TI>
<SO>Contraception</SO>
<YR>2009</YR>
<VL>80</VL>
<NO>2</NO>
<PG>108-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Trussell-2011" MODIFIED="2013-07-18 13:33:15 -0400" MODIFIED_BY="[Empty name]" NAME="Trussell 2011" TYPE="JOURNAL_ARTICLE">
<AU>Trussell J</AU>
<TI>Contraceptive failure in the United States</TI>
<SO>Contraception</SO>
<YR>2011</YR>
<VL>83</VL>
<NO>5</NO>
<PG>397-404</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-UN-2011" MODIFIED="2013-07-18 13:39:15 -0400" MODIFIED_BY="[Empty name]" NAME="UN 2011" TYPE="OTHER">
<AU>United Nations, Department of Economic and Social Affairs</AU>
<TI>World Contraceptive Use - 2011</TI>
<SO>http://www.un.org/esa/population/publications/contraceptive2011/contraceptive2011.htm</SO>
<YR>(accessed 21 Feb 2013)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Westhoff-2007" MODIFIED="2013-08-14 14:59:11 -0400" MODIFIED_BY="[Empty name]" NAME="Westhoff 2007" NOTES="&lt;p&gt;Westhoff, Carolyn&lt;br&gt;Heartwell, Stephen&lt;br&gt;Edwards, Sharon&lt;br&gt;Zieman, Mimi&lt;br&gt;Cushman, Linda&lt;br&gt;Robilotto, Christina&lt;br&gt;Stuart, Gretchen&lt;br&gt;Morroni, Chelsea&lt;br&gt;Kalmuss, Debra&lt;br&gt;eng&lt;br&gt;HD42413/HD/NICHD NIH HHS/&lt;br&gt;Randomized Controlled Trial&lt;br&gt;Research Support, N.I.H., Extramural&lt;br&gt;2007/06/02 09:00&lt;br&gt;Obstet Gynecol. 2007 Jun;109(6):1270-6.&lt;/p&gt;" NOTES_MODIFIED="2013-08-14 14:59:11 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Westhoff C, Heartwell S, Edwards S, Zieman M, Cushman L, Robilotto C, et al</AU>
<TI>Initiation of oral contraceptives using a quick start compared with a conventional start: a randomized controlled trial</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2007</YR>
<VL>109</VL>
<NO>6</NO>
<PG>1270-6</PG>
<IDENTIFIERS MODIFIED="2013-08-14 14:59:11 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-White-2011" MODIFIED="2013-08-14 14:59:06 -0400" MODIFIED_BY="[Empty name]" NAME="White 2011" NOTES="&lt;p&gt;White, Katharine O'Connell&lt;br&gt;Westhoff, Carolyn&lt;br&gt;eng&lt;br&gt;1 FPRPA006025-01-00/PHS HHS/&lt;br&gt;Randomized Controlled Trial&lt;br&gt;Research Support, U.S. Gov't, P.H.S.&lt;br&gt;2011/08/24 06:00&lt;br&gt;Obstet Gynecol. 2011 Sep;118(3):615-22. doi: 10.1097/AOG.0b013e3182289eab.&lt;/p&gt;" NOTES_MODIFIED="2013-08-14 14:59:06 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>White KO, Westhoff C</AU>
<TI>The effect of pack supply on oral contraceptive pill continuation: a randomized controlled trial</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2011</YR>
<VL>118</VL>
<NO>3</NO>
<PG>615-22</PG>
<IDENTIFIERS MODIFIED="2013-08-14 14:59:06 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES MODIFIED="2013-07-15 09:00:33 -0400" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2013-08-14 14:56:04 -0400" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2013-08-14 14:56:04 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2013-07-18 11:36:25 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Berenson-2012">
<CHAR_METHODS MODIFIED="2013-07-08 16:12:06 -0400" MODIFIED_BY="[Empty name]">
<P>Location: Southeast Texas (USA); enrollment from Jul 2006 to Jan 2010.</P>
<P>Sample size calculation (and outcome of focus): N=190 in each group (570 total) for 90% power to detect OR of 2.0 for oral contraceptive (OC) continuation after 12 months.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-07-08 16:12:06 -0400" MODIFIED_BY="[Empty name]">
<P>General with N: 1155 women, 16 to 24 years of age</P>
<P>Source: 5 public clinics for reproductive health serving low income women.</P>
<P>Inclusion criteria: sexually active, non-pregnant females, 16 to 24 years old, requesting OC initiation.</P>
<P>Exclusion criteria: desire to become pregnant in next year, medical contraindication to OC, current or prior (&gt;1 month) OC use.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-18 11:36:25 -0400" MODIFIED_BY="[Empty name]">
<P>1) Counseling plus phone (C+P): counseling (below) plus phone calls by contraceptive counselor (weekly until initiation then monthly for 6 months) and access to 24-hour toll-free number;</P>
<P>2) Counseling (C): standard care plus 45 minutes of contraceptive counseling from study staff;</P>
<P>3) Standard care from nurse practitioner with written protocol for new OC users.<BR/>Duration: 6-month intervention; telephone follow up at 3, 6 and 12 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-07-08 16:12:06 -0400" MODIFIED_BY="[Empty name]">
<P>OC adherence (consistent OC use), pregnancy (self-report and medical record review)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-07-08 16:18:53 -0400" MODIFIED_BY="[Empty name]">
<P>Losses to follow up by 12 months: 44% counseling, 43% counseling + phone, and 45% standard care.</P>
<P>Exclusions after randomization: none apparent</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-07-30 14:48:39 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Canto-De-Cetina-2001">
<CHAR_METHODS MODIFIED="2013-07-30 14:40:33 -0400" MODIFIED_BY="[Empty name]">
<P>Methods of randomization are not reported.<BR/>One site at 'Centro de Investigaciones Hideyo Noguchi,' Merida, Yucatan (Mexico).<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>350 women attending the Family Planning Clinic and willing to use DMPA for contraception. Inclusion criteria were: between the ages of 18 and 35 years old, living in a rural area; proven fertility; regular menstrual cycles during the previous six months; not breastfeeding; at least one child; normal PAP smear; willing to use DMPA as the only contraceptive agent during the course of the study; willing to return to the clinic every three months. Exclusion criteria were: current or history of thrombophlebitis; thromboembolic disorders; hypertension; cerebral vascular disease; active or chronic liver disease; known or suspected breast or genital organ malignancy; endocrinopathy undiagnosed; vaginal bleeding; diabetes mellitus.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-30 14:48:39 -0400" MODIFIED_BY="[Empty name]">
<P>Structured pre-treatment and follow-up counseling versus routine pre-treatment counseling.</P>
<P>Follow-up visits coincided with injection time, which was every 3 months for 1 year.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Cumulative life table discontinuation rate, reason for discontinuation, DMPA-induced side effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-03-07 09:25:31 -0500" MODIFIED_BY="[Empty name]">
<P>Losses to follow up: Counseling group, 1%; Control group, 2%.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-07-30 15:27:55 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Casta_x00f1_o-2012">
<CHAR_METHODS MODIFIED="2013-07-30 13:06:35 -0400" MODIFIED_BY="[Empty name]">
<P>Location: Brooklyn, NY (USA); enrollment from March 2008 to July 2009</P>
<P>Sample size calculation (and outcome of focus): detect 10% change in OC continuation between groups, assuming 40% continuation at 6 months in routine-care group; N=480 needed in each group.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-07-30 13:06:32 -0400" MODIFIED_BY="[Empty name]">
<P>General with N: 962 women younger than 25 years<BR/>Source: family planning health center</P>
<P>Inclusion criteria: sexually active; owned a cell phone with text messaging functionality; no medical contraindications to oral contraceptive use.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-30 15:27:55 -0400" MODIFIED_BY="[Empty name]">
<P>1) Routine care, including contraceptive counseling and handout.</P>
<P>2) Routine care plus 180 daily text messages (reminders to take OC daily; short education messages addressing 6 domains of OC knowledge: risks, benefits, side effects, use, effectiveness, and mechanisms of action). Message length &lt; 160 characters.</P>
<P>Participants were followed for six months.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-07-29 16:25:49 -0400" MODIFIED_BY="[Empty name]">
<P>OC continuation (participant had taken pill during the last 7 days) assessed by phone at 6 months after enrollment. </P>
<P>Also missed pills, interruptions in OC use &gt; 7 days, use of OC at last sexual intercourse.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-07-29 16:16:51 -0400" MODIFIED_BY="[Empty name]">
<P>Losses to follow up: 28% for treatment and 30% for control.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-05 15:28:33 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gilliam-2004">
<CHAR_METHODS MODIFIED="2013-07-29 15:40:08 -0400" MODIFIED_BY="[Empty name]">
<P>One site at Northwestern Memorial Hospital, Chicago, IL (USA); 1998 to 1999.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-10-29 08:55:29 -0400" MODIFIED_BY="Laureen M Lopez">
<P>33 African American low-income females attending Prentice Ambulatory Care. This resident-run clinic serves low-income women receiving public assistance. Inclusion criteria: 25 years or younger; with unplanned pregnancy; intending to use OCs postpartum. Exclusion criterion: history of consistent or successful oral contraceptive (OC) use prior to pregnancy.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-30 14:56:49 -0400" MODIFIED_BY="[Empty name]">
<P>Usual care: Prior to discharge, all participants received the standard postpartum counseling. Residents discussed how to take the pill, what to do if a pill is missed, side effects and risks and benefits of OCs. Participants received three labeled pill packets with instructions and phone numbers for 24-hour access if they had questions.</P>
<P>Experimental intervention: Antepartum, multi-component intervention consisting of counseling, videotape about OCs, and written material.</P>
<P>Participants were followed for one year.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-05 15:28:33 -0400" MODIFIED_BY="[Empty name]">
<P>Continuation rate at one year, switch to other contraceptives at one year; </P>
<P>pregnancy rate at one year for 9 women (from delivery records or self-report).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-01-10 13:10:11 -0500" MODIFIED_BY="[Empty name]">
<P>Knowledge of OCs mentioned, but data reported elsewhere. 43 women were enrolled in the Chicago study but only 33 were randomized. Reasons for study enrollment without randomization included participants changing their mind about using OCs, delivering at an outside hospital, and failure of the study team to randomize the participant prior to leaving the hospital due to miscommunication with nursing staff or leaving after a 24-hour rather than 48-hour stay.</P>
<P>Losses to follow up: by 1 year, 52% dropped out. Pregnancy data were obtained on 9 of the women that dropped out via records or contacting participant, leaving data loss for 8/33 = 24%.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-19 08:21:37 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hou-2010">
<CHAR_METHODS MODIFIED="2010-12-20 16:00:43 -0500" MODIFIED_BY="[Empty name]">
<P>Family planning clinic in Boston, MA (USA).<BR/>Intervention lasted 3 months.<BR/>Sample size calculation based on data from an earlier study: ability to detect 1.6-pill improvement with two-sided test at 90% power.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-12-20 15:56:46 -0500" MODIFIED_BY="[Empty name]">
<P>82 women seeking care at the clinic. Inclusion criteria: personal mobile phone with text-messaging capabilities and desire to use OC for at least 6 months<BR/>Exclusion criteria: contraindication to OC use, use of OC primarily for non-contraceptive indications, current use of OC for more than 1 month, intent of pregnancy in the next 12 months, plans to travel outside the cell phone networks of USA and Canada during the study, inability to complete the study, and being in situation in which receipt of a text-message reminder to take OC would endanger the safety and privacy of the woman</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-12-20 15:54:28 -0500" MODIFIED_BY="[Empty name]">
<P>Daily text message to remember to take OC; control did not receive reminders.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-12-20 15:57:39 -0500" MODIFIED_BY="[Empty name]">
<P>Number of missed pills per cycle, measured with electronic monitoring device and diary</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-01-19 08:21:37 -0500" MODIFIED_BY="[Empty name]">
<P>Losses to follow up: reportedly 12% for treatment and 10% for control.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-07-29 15:40:39 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jay-1984">
<CHAR_METHODS MODIFIED="2013-07-29 15:40:34 -0400" MODIFIED_BY="[Empty name]">
<P>One site of the Title V Children and Youth Project for the State of Georgia (USA).<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>57 adolescents attending adolescent gynecology clinic and were willing to use oral contraceptives.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-29 15:40:39 -0400" MODIFIED_BY="[Empty name]">
<P>Peer versus nurse counseling at three appointments for both groups.</P>
<P>Participants were followed for four months.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-07-18 08:45:51 -0400" MODIFIED_BY="[Empty name]">
<P>Noncompliance measured by a Guttman scale consisting of 1) avoidance of pregnancy, 2) appointment adherence, 3) pill count, 4) urinary fluorescence for riboflavin.<BR/>Second outcome was attrition rate at four months (end of study); defined as failing to keep the second rescheduled broken appointment or discontinuing the oral contraceptive regimen.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-03-07 09:25:32 -0500" MODIFIED_BY="[Empty name]">
<P>31 (54%) subjects were assigned to the nurse-counselor group, and 26 (46%) were assigned to the peer-counselor group. 50% (28 or 29) of the participants were expected to be assigned to each group. A sampling error of this degree was not significant with a sample size of 57.<BR/>Losses to follow up: 33% overall; nurse-counseled, 42%; peer-counseled, 23%</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-14 14:56:04 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Keder-1998">
<CHAR_METHODS MODIFIED="2013-07-29 15:40:49 -0400" MODIFIED_BY="[Empty name]">
<P>One site at the Magee-Womens Hospital clinic in Pittsburgh, PA (USA).<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-08-14 14:56:04 -0400" MODIFIED_BY="[Empty name]">
<P>250 women attending the clinic and willing to use DMPA for contraception. Inclusion criteria were access to a telephone and planning to return to the same facility for continuing care. Exclusion criteria were currently receiving depot medroxyprogesterone treatment, planning to undergo tubal ligation, immediately postpartum, unwilling to provide back-up contact information.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-29 15:40:53 -0400" MODIFIED_BY="[Empty name]">
<P>Mail and telephone reminders of the next injection two weeks before each scheduled injection versus written appointment card.</P>
<P>Participants were followed for 12 months.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Discontinuation rate at 12 months, rate of on-time injections, reason for discontinuation, DMPA-induced side effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-07-30 14:44:48 -0400" MODIFIED_BY="[Empty name]">
<P>An injection received within 14 weeks of the prior injection was classified as 'on-time' injection.<BR/>Losses to follow up: according to data provided by researcher, 36% overall; reminder group, 39%; no reminder group, 33%. The report had noted 17.6% loss for the year-end interview.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-07-31 09:51:28 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kirby-2010">
<CHAR_METHODS MODIFIED="2011-01-19 08:22:53 -0500" MODIFIED_BY="[Empty name]">
<P>Location: San Francisco, CA (USA)<BR/>Sample size calculation (and outcome of focus): 80% chance of finding 10-percentage-point difference in proportion of women who used hormonal contraception for 6 months or longer</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-12-20 15:37:38 -0500" MODIFIED_BY="[Empty name]">
<P>General with N: 805 females, 14 to 18 years old<BR/>Source: reproductive health clinic for adolescents and young adults<BR/>Inclusion criteria: not pregnant or trying to become pregnant, had sex in the last 3 months, no consistent hormonal contraception for 3 months and no IUD or contraceptive implant<BR/>Exclusion criteria: ns</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-31 09:51:28 -0400" MODIFIED_BY="[Empty name]">
<P>Study focus: improve contraceptive use, reduce unintended pregnancy and STI<BR/>Treatment: Intense phone follow-up after initial visit (9 calls planned) using motivational interviewing<BR/>Comparison or control: regular clinic services<BR/>Duration: 12 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-12-20 16:02:58 -0500" MODIFIED_BY="[Empty name]">
<P>Correct use of hormonal contraceptive (injectable, patch, OC), self-reported pregnancy<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-01-10 13:10:42 -0500" MODIFIED_BY="[Empty name]">
<P>Losses to follow up: reported as 22% at 6 months, 25% at 18 months; reportedly did not differ by group<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-07 14:11:34 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Trent-2013">
<CHAR_METHODS MODIFIED="2013-08-07 14:11:34 -0400" MODIFIED_BY="[Empty name]">
<P>Location: Baltimore, MD (USA); Jan 2011 to Mar 2012.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-07-30 15:32:33 -0400" MODIFIED_BY="[Empty name]">
<P>General with N: 100 urban adolescent girls</P>
<P>Source: urban academic practice</P>
<P>Inclusion criteria: age 13 to 21 years, willing to be randomized, currently using DMPA, have cellular phone with text messaging capability for personal use. </P>
<P>Exclusion criteria: using other forms of contraception, do not have cell phone with text messaging capability for personal use.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-07 14:11:05 -0400" MODIFIED_BY="[Empty name]">
<P>1) Intervention: starting 72 hours before clinical visit, daily text appointment reminders; monthly healthy self-management messages during enrollment period (condom used, weight control, side effect management, STD testing reminder); call for missed appointment or no reply to appointment reminder (or other text message).</P>
<P>2) Standard care: counseling and clinic appointment reminders; call from nurse case manager after missing scheduled re-injection appointment</P>
<P>Duration: 3 injection cycles</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-07-30 14:03:36 -0400" MODIFIED_BY="[Empty name]">
<P>Appointment adherence by 9 months (3 injection appointments)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-08-07 14:10:57 -0400" MODIFIED_BY="[Empty name]">
<P>Information obtained from published abstract, ClinicalTrials.gov listing, and communication with investigator. Trial was recently finished; full paper was being submitted.</P>
<P>Eighty-seven percent of participants completed all 3 DMPA cycles.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ns - not specified in report</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2013-07-24 05:07:06 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2013-07-24 05:06:13 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Andolsek-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-24 05:06:13 -0400" MODIFIED_BY="[Empty name]">
<P>Outcome measures were not limited to hormonal methods, but rather grouped hormonal and non-hormonal methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-22 11:58:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Behboodi-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-22 11:58:19 -0400" MODIFIED_BY="[Empty name]">
<P>The study was 'quasi-experimental.' Investigator communicated that one of two health centers in the city was assigned as the case group, which received BASNEF model classes. The other health center was assigned as control group and they had routine education. Study is reportedly complete and a paper is undergoing peer-review for a journal.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bender-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Did not evaluate any outcomes relevant to this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-24 05:07:06 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Burnhill-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-24 05:07:06 -0400" MODIFIED_BY="[Empty name]">
<P>Intervention was individualized and did not focus on hormonal methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-10 14:39:48 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Carneiro-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-10 14:39:48 -0400" MODIFIED_BY="[Empty name]">
<P>Not specific to hormonal methods; included condoms and IUDs (in general).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-08 14:52:47 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gilliam-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-08 14:52:47 -0400" MODIFIED_BY="[Empty name]">
<P>Two study arms assigned to different contraceptive methods; however, both received the same reminders.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-15 15:12:42 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Langston-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-15 15:12:42 -0400" MODIFIED_BY="[Empty name]">
<P>Outcome was continuation of very effective or effective method. 'Very effective' was a combination of non-hormonal and hormonal methods (sterilization, IUDs, implants).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-22 11:22:53 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Madden-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-22 11:22:53 -0400" MODIFIED_BY="[Empty name]">
<P>Not a randomized controlled trial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Metson-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomized controlled trial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Roye-2007">
<CHAR_REASON_FOR_EXCLUSION>
<P>Women could be using one of several hormonal contraceptives. Intervention focused on condom use for HIV prevention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Schunmann-2006">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomized controlled trial; used alternate assignment.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-22 11:53:30 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schwandt-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-22 11:53:30 -0400" MODIFIED_BY="[Empty name]">
<P>No relevant outcome measure (knowledge and intention to use). Intervention did not focus on hormonal methods.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-10-29 10:06:32 -0400" MODIFIED_BY="Laureen M Lopez" STUDY_ID="STD-Schwarz-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-10-29 10:06:32 -0400" MODIFIED_BY="Laureen M Lopez">
<P>Control group was given information on folate supplementation, but no family planning counseling.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-10-14 16:08:39 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Westhoff-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-10-14 16:08:39 -0400" MODIFIED_BY="[Empty name]">
<P>Outcome not relevant to this review (choice of contraceptive on enrollment day)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-11-01 11:04:52 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhu-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-11-01 11:04:52 -0400" MODIFIED_BY="[Empty name]">
<P>Analysis of pregnancy grouped all types of contraceptives and no method use. For OCs, 'regular use' was not defined, though counts were provided.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2013-07-16 12:44:53 -0400" MODIFIED_BY="Laureen M Lopez" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2013-08-07 14:09:40 -0400" MODIFIED_BY="Laureen M Lopez" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2013-08-07 14:09:40 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Smith-2013">
<CHAR_STUDY_NAME MODIFIED="2013-07-30 13:09:37 -0400" MODIFIED_BY="[Empty name]">
<P>Mobile Technology for Improved Family Planning (MOTIF)</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-07-30 13:40:00 -0400" MODIFIED_BY="[Empty name]">
<P>Location: 4 clinics in Cambodia</P>
<P>RCT, single blind (outcome assessor); evaluate effectiveness of voice-based mobile phone health (mHealth) intervention to support post-abortion family planning (PAFP)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-07-30 13:41:48 -0400" MODIFIED_BY="[Empty name]">
<P>Estimated enrollment: 500 women, aged 18 years and older</P>
<P>Inclusion criteria: attending for abortion, doesn't want to have a child at current time, age &gt;= 18 years, owns mobile phone, willing to receive simple voice messages relating to contraception in Khmer language. </P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-07 14:09:40 -0400" MODIFIED_BY="[Empty name]">
<P>1) Mobile phone-based intervention: standard care (below) plus automated voice message to support post-abortion contraception use every two weeks, and follow up phone call by family planning counselor depending on response to voice message.</P>
<P>2) Standard care: face-to-face post-abortion family planning (PAFP) counseling, follow up<BR/>at one or two weeks, clinic phone number, existing 'Hotline' phone number.</P>
<P>Duration: 3 months; outcomes assessed at 4 months post-abortion</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-07-30 13:48:38 -0400" MODIFIED_BY="[Empty name]">
<P>Primary: self-reported use of pill, coil, implant or injection for all participants; </P>
<P>objective measurement of contraceptive use for participants from one clinic (no detail). </P>
<P>Secondary: pregnancy, repeat abortion, and contraceptive discontinuation.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-07-30 13:38:28 -0400" MODIFIED_BY="[Empty name]">
<P>May 2013; estimated completion Dec 2013</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-07-30 13:47:11 -0400" MODIFIED_BY="[Empty name]">
<P>Chris GJ Smith, MBBCh MSc; +85589421536; christopher.smith@lshtm.ac.uk</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-07-30 13:47:17 -0400" MODIFIED_BY="[Empty name]"/>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2013-07-30 14:45:01 -0400" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2013-07-29 16:11:15 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-08 16:19:03 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Berenson-2012">
<DESCRIPTION>
<P>Computer-generated randomization scheme (PLAN procedure, SAS Institute)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-20 15:42:17 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Canto-De-Cetina-2001">
<DESCRIPTION>
<P>ns</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-29 16:11:15 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Casta_x00f1_o-2012">
<DESCRIPTION>
<P>Random number table used with blocks of four.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-08 14:40:39 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gilliam-2004">
<DESCRIPTION>
<P>Computer-generated random numbers table; randomized following delivery</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-20 15:54:56 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hou-2010">
<DESCRIPTION>
<P>Computer-generated with varying block sizes of 4 and 6</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-20 15:43:21 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jay-1984">
<DESCRIPTION>
<P>Computer-generated random numbers table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-20 15:43:42 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Keder-1998">
<DESCRIPTION>
<P>Computer-generated randomization list</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-20 15:40:47 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kirby-2010">
<DESCRIPTION>
<P>random number generator; participants were stratified by age</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-29 15:42:57 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Trent-2013">
<DESCRIPTION>
<P>Computer-generated randomization sequence, according to investigator's communication</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2013-07-29 16:15:25 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-08 16:19:13 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Berenson-2012">
<DESCRIPTION>
<P>When asked about concealment before assignment, investigator communicated that they did not conceal it from the researchers but did conceal it from the patient.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-20 15:42:22 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Canto-De-Cetina-2001">
<DESCRIPTION>
<P>ns</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-29 16:15:25 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Casta_x00f1_o-2012">
<DESCRIPTION>
<P>Opaque, sequentially-numbered, sealed envelopes. Investigators masked to allocation while randomizing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-18 09:06:14 -0400" MODIFIED_BY="Laureen M Lopez" RESULT="YES" STUDY_ID="STD-Gilliam-2004">
<DESCRIPTION>
<P>Study packets were in envelopes that "concealed the contents"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-19 08:22:32 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hou-2010">
<DESCRIPTION>
<P>Opaque, sequentially-numbered envelopes; did not state whether envelopes were sealed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-20 15:43:25 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jay-1984">
<DESCRIPTION>
<P>ns</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-20 15:43:48 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Keder-1998">
<DESCRIPTION>
<P>ns</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-20 15:40:45 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kirby-2010">
<DESCRIPTION>
<P>ns</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-29 15:44:50 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Trent-2013">
<DESCRIPTION>
<P>Randomization concealed prior to assignment, according to investigator's communication. Research staff opened a packet, which contained randomization status and pertinent information for next steps in the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2013-07-30 14:45:01 -0400" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-07-08 16:19:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Berenson-2012">
<DESCRIPTION>
<P>Single-blinded study; staff who made assessment phone calls were blinded to intervention group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-12-20 15:45:15 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Canto-De-Cetina-2001">
<DESCRIPTION>
<P>Not clear if blinding of investigators and evaluators of the study outcomes was maintained</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-07-29 16:15:32 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Casta_x00f1_o-2012">
<DESCRIPTION>
<P>None used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-12-20 15:43:02 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gilliam-2004">
<DESCRIPTION>
<P>Research team members were reportedly blind to group participation; details not provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-12-20 15:49:43 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hou-2010">
<DESCRIPTION>
<P>Investigator-blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-12-20 15:45:57 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jay-1984">
<DESCRIPTION>
<P>Urine samples for fluorescence were evaluated in a double-blind fashion by 3 independent observers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-07-30 14:45:01 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Keder-1998">
<DESCRIPTION>
<P>Women enrolled were told of their assignment; researchers not blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-12-20 15:40:49 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kirby-2010">
<DESCRIPTION>
<P>single blind (outcome assessor)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-07-29 15:43:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Trent-2013">
<DESCRIPTION>
<P>PI was blinded to patient's enrollment status (single blind), according to investigator's communication</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2013-07-08 09:29:48 -0400" MODIFIED_BY="Laureen M Lopez"/>
<ADDITIONAL_TABLES MODIFIED="2013-09-05 11:16:54 -0400" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2013-08-14 15:04:11 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2011-01-06 15:25:29 -0500" MODIFIED_BY="[Empty name]">Correct use of contraceptives: motivational phone calls versus usual care (Kirby 2010)</TITLE>
<TABLE COLS="6" ROWS="6">
<TR>
<TH ROWSPAN="2">
<P>Outcome<SUP>1</SUP>
<BR/>
</P>
</TH>
<TH ROWSPAN="2">
<P>N</P>
</TH>
<TH ALIGN="CENTER" COLSPAN="2">
<P>6 months</P>
</TH>
<TH ALIGN="CENTER" COLSPAN="2">
<P>18 months</P>
</TH>
</TR>
<TR>
<TH ALIGN="CENTER">
<P>Effect size</P>
</TH>
<TH ALIGN="CENTER">
<P>P value</P>
</TH>
<TH ALIGN="CENTER">
<P>Effect size</P>
</TH>
<TH ALIGN="CENTER">
<P>P</P>
</TH>
</TR>
<TR>
<TD>
<P>Correct use of DMPA: injection on schedule in last 3 months (% yes)</P>
</TD>
<TD>
<P>127</P>
</TD>
<TD ALIGN="CENTER">
<P>1.90</P>
</TD>
<TD ALIGN="CENTER">
<P>0.34</P>
</TD>
<TD ALIGN="CENTER">
<P>1.70</P>
</TD>
<TD ALIGN="CENTER">
<P>0.42</P>
</TD>
</TR>
<TR>
<TD>
<P>Correct use of patch: patch stayed on for week during last month (% yes)</P>
</TD>
<TD>
<P>152</P>
</TD>
<TD ALIGN="CENTER">
<P>0.95</P>
</TD>
<TD ALIGN="CENTER">
<P>0.75</P>
</TD>
<TD ALIGN="CENTER">
<P>0.60</P>
</TD>
<TD ALIGN="CENTER">
<P>0.74</P>
</TD>
</TR>
<TR>
<TD>
<P>Correct use of patch: applied new patch each week for 3 weeks,<BR/>then waited a week (during last month (% yes))</P>
</TD>
<TD>
<P>153</P>
</TD>
<TD ALIGN="CENTER">
<P>0.86</P>
</TD>
<TD ALIGN="CENTER">
<P>0.95</P>
</TD>
<TD ALIGN="CENTER">
<P>0.57</P>
</TD>
<TD ALIGN="CENTER">
<P>0.72</P>
</TD>
</TR>
<TR>
<TD>
<P>Correct use of pill: number of pills missed last month</P>
</TD>
<TD>
<P>308</P>
</TD>
<TD ALIGN="CENTER">
<P>-0.01</P>
</TD>
<TD ALIGN="CENTER">
<P>0.94</P>
</TD>
<TD ALIGN="CENTER">
<P>0.07</P>
</TD>
<TD ALIGN="CENTER">
<P>0.56</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>Investigators provided these results from adjusted multivariate analyses.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2013-09-05 11:16:54 -0400" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2013-07-08 09:29:48 -0400" MODIFIED_BY="[Empty name]">Results by quality of evidence</TITLE>
<TABLE COLS="7" ROWS="10">
<TR>
<TH>
<P>Study</P>
</TH>
<TH>
<P>Randomization<BR/>and allocation<BR/>concealment</P>
</TH>
<TH ALIGN="CENTER">
<P>No objective<BR/>outcome</P>
</TH>
<TH>
<P>Losses<BR/>&gt; 20%</P>
</TH>
<TH ALIGN="CENTER">
<P>Limited<BR/>intervention<BR/>
</P>
</TH>
<TH>
<P>Quality of<BR/>evidence<SUP>1</SUP>
</P>
</TH>
<TH>
<P>Evidence<BR/>of effect</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Trent-2013" TYPE="STUDY">Trent 2013</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD>
<P>High</P>
</TD>
<TD>
<P>no</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Jay-1984" TYPE="STUDY">Jay 1984</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD ALIGN="CENTER">
<P>-1</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD>
<P>Moderate</P>
</TD>
<TD ALIGN="LEFT">
<P>no</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Gilliam-2004" TYPE="STUDY">Gilliam 2004</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD ALIGN="CENTER">
<P>-1</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD>
<P>Moderate</P>
</TD>
<TD ALIGN="LEFT">
<P>no</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Hou-2010" TYPE="STUDY">Hou 2010</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD ALIGN="CENTER">
<P>-1</P>
</TD>
<TD>
<P>Moderate</P>
</TD>
<TD ALIGN="LEFT">
<P>no</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Berenson-2012" TYPE="STUDY">Berenson 2012</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD ALIGN="CENTER">
<P>-1</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD>
<P>Moderate</P>
</TD>
<TD ALIGN="LEFT">
<P>yes</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Canto-De-Cetina-2001" TYPE="STUDY">Canto De Cetina 2001</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>-1</P>
</TD>
<TD ALIGN="CENTER">
<P>-1</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD>
<P>Low</P>
</TD>
<TD ALIGN="LEFT">
<P>yes</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Keder-1998" TYPE="STUDY">Keder 1998</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD ALIGN="CENTER">
<P>-1</P>
</TD>
<TD ALIGN="CENTER">
<P>-1</P>
</TD>
<TD>
<P>Low</P>
</TD>
<TD ALIGN="LEFT">
<P>no</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kirby-2010" TYPE="STUDY">Kirby 2010</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD ALIGN="CENTER">
<P>-1</P>
</TD>
<TD ALIGN="CENTER">
<P>-1</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD>
<P>Low</P>
</TD>
<TD ALIGN="LEFT">
<P>no</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Casta_x00f1_o-2012" TYPE="STUDY">Castaño 2012</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD ALIGN="CENTER">
<P>-1</P>
</TD>
<TD ALIGN="CENTER">
<P>-1</P>
</TD>
<TD ALIGN="CENTER">
<P>---</P>
</TD>
<TD>
<P>Low</P>
</TD>
<TD ALIGN="LEFT">
<P>yes</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>RCTs were considered high quality then downgraded a level for each of the following: a) randomization sequence generation and allocation concealment: no information on either, or one was inadequate; b) outcomes all self-reported or data unavailable for objective outcomes; c) losses &gt; 20%; d) intervention focused on reminders without additional health education.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2013-08-07 14:01:53 -0400" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2013-07-23 14:01:57 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Peer counseling versus nurse counseling</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.4588906553736901" CI_START="-0.8788906553736903" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.21000000000000008" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.5383329138321558" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="20" TOTAL_2="18" UNITS="" WEIGHT="100.0" Z="0.6153359049745829">
<NAME>Non-compliance (Guttman score) at four months</NAME>
<GROUP_LABEL_1>Peer (treatment)</GROUP_LABEL_1>
<GROUP_LABEL_2>Nurse (control)</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.4588906553736901" CI_START="-0.8788906553736903" EFFECT_SIZE="-0.21000000000000008" ESTIMABLE="YES" MEAN_1="0.85" MEAN_2="1.06" ORDER="130" SD_1="0.98" SD_2="1.11" SE="0.3412770135828078" STUDY_ID="STD-Jay-1984" TOTAL_1="20" TOTAL_2="18" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.322552092273254" CI_START="0.13046320043367735" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.4153846153846154" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.12141278690100538" LOG_CI_START="-0.8845119718687419" LOG_EFFECT_SIZE="-0.3815495924838682" METHOD="MH" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.13705766482845397" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="26" TOTAL_2="31" WEIGHT="100.0" Z="1.4868377640866688">
<NAME>Attrition at four months</NAME>
<GROUP_LABEL_1>Peer (treatment)</GROUP_LABEL_1>
<GROUP_LABEL_2>Nurse (control)</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3225520922732539" CI_START="0.13046320043367735" EFFECT_SIZE="0.4153846153846154" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="13" LOG_CI_END="0.1214127869010053" LOG_CI_START="-0.8845119718687419" LOG_EFFECT_SIZE="-0.3815495924838682" ORDER="131" O_E="0.0" SE="0.5908851827092122" STUDY_ID="STD-Jay-1984" TOTAL_1="26" TOTAL_2="31" VAR="0.3491452991452991" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2013-08-07 14:01:53 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Multicomponent intervention versus routine counseling</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="6.155739195048448" CI_START="0.2121796274329182" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.789280211459848" LOG_CI_START="-0.6732963175044746" LOG_EFFECT_SIZE="0.05799194697768673" METHOD="MH" MODIFIED="2011-01-10 11:03:25 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.8764844990159426" Q="0.0" RANDOM="NO" SCALE="16.8244114598391" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="18" TOTAL_2="15" WEIGHT="100.0" Z="0.15542725487343723">
<NAME>Continuation of oral contraceptives at one year</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="6.155739195048448" CI_START="0.2121796274329182" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.789280211459848" LOG_CI_START="-0.6732963175044746" LOG_EFFECT_SIZE="0.05799194697768673" ORDER="126" O_E="0.0" SE="0.8591246929842246" STUDY_ID="STD-Gilliam-2004" TOTAL_1="18" TOTAL_2="15" VAR="0.738095238095238" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="15.38145094155205" CI_START="0.6657369346306119" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="1.1869973046583988" LOG_CI_START="-0.17669734801858689" LOG_EFFECT_SIZE="0.505149978319906" METHOD="MH" MODIFIED="2013-08-07 14:01:53 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.14648796647152293" Q="0.0" RANDOM="NO" SCALE="30.4258591762675" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="18" TOTAL_2="15" WEIGHT="100.0" Z="1.452049052703474">
<NAME>Switched contraceptives by one year</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="15.38145094155205" CI_START="0.6657369346306119" EFFECT_SIZE="3.2" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" LOG_CI_END="1.1869973046583988" LOG_CI_START="-0.17669734801858689" LOG_EFFECT_SIZE="0.505149978319906" ORDER="128" O_E="0.0" SE="0.8010409893798611" STUDY_ID="STD-Gilliam-2004" TOTAL_1="18" TOTAL_2="15" VAR="0.6416666666666667" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.506233020860925" CI_START="0.059751710893018575" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.3" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="0.17789216432527102" LOG_CI_START="-1.2236496548859461" LOG_EFFECT_SIZE="-0.5228787452803376" METHOD="MH" MODIFIED="2013-08-07 14:01:53 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.14362532539978942" Q="0.0" RANDOM="NO" SCALE="26.949946517858514" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="18" TOTAL_2="15" WEIGHT="100.0" Z="1.462423018683412">
<NAME>Loss to follow up</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.506233020860925" CI_START="0.059751710893018575" EFFECT_SIZE="0.3" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.17789216432527102" LOG_CI_START="-1.2236496548859461" LOG_EFFECT_SIZE="-0.5228787452803376" ORDER="129" O_E="0.0" SE="0.8232726023485646" STUDY_ID="STD-Gilliam-2004" TOTAL_1="18" TOTAL_2="15" VAR="0.6777777777777778" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2013-07-30 15:11:27 -0400" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Counseling + phone calls versus counseling versus standard care</NAME>
<DICH_OUTCOME CHI2="0.9227673410102601" CI_END="1.6143961688186894" CI_START="1.0318529080828964" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="OR" EFFECT_SIZE="1.2906662549216399" ESTIMABLE="YES" EVENTS_1="300" EVENTS_2="260" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.20801011825428437" LOG_CI_START="0.01361779248413132" LOG_EFFECT_SIZE="0.11081395536920788" METHOD="MH" MODIFIED="2013-07-08 16:15:50 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.33674955001748674" P_Q="0.336749620616031" P_Z="0.025445773526643727" Q="0.9227670713543525" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="768" TOTAL_2="766" WEIGHT="200.0" Z="2.2345672407343966">
<NAME>Consistent OC use: counseling + phone versus counseling</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.8715892031577288" CI_START="1.0582329089445581" DF="0" EFFECT_SIZE="1.4073298429319372" ESTIMABLE="YES" EVENTS_1="224" EVENTS_2="191" I2="0.0" ID="CMP-003.01.01" LOG_CI_END="0.2722105311650746" LOG_CI_START="0.024581263103045592" LOG_EFFECT_SIZE="0.1483958971340601" MODIFIED="2013-07-08 16:15:50 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.01881980835491051" STUDIES="1" TAU2="0.0" TOTAL_1="384" TOTAL_2="383" WEIGHT="100.0" Z="2.349081076824997">
<NAME>At 3 months</NAME>
<DICH_DATA CI_END="1.8715892031577288" CI_START="1.0582329089445581" EFFECT_SIZE="1.4073298429319372" ESTIMABLE="YES" EVENTS_1="224" EVENTS_2="191" LOG_CI_END="0.2722105311650746" LOG_CI_START="0.024581263103045592" LOG_EFFECT_SIZE="0.1483958971340601" MODIFIED="2013-07-08 16:15:50 -0400" MODIFIED_BY="[Empty name]" ORDER="20" O_E="0.0" SE="0.14545865784428194" STUDY_ID="STD-Berenson-2012" TOTAL_1="384" TOTAL_2="383" VAR="0.021158221141859886" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.6124515030726154" CI_START="0.7819882091419217" DF="0" EFFECT_SIZE="1.1229060794278185" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="69" I2="0.0" ID="CMP-003.01.02" LOG_CI_END="0.20748666143773375" LOG_CI_START="-0.10679979520512034" LOG_EFFECT_SIZE="0.050343433116306686" MODIFIED="2013-07-08 16:15:50 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.5300649408234306" STUDIES="1" TAU2="0.0" TOTAL_1="384" TOTAL_2="383" WEIGHT="100.0" Z="0.6279068899121502">
<NAME>At 12 months</NAME>
<DICH_DATA CI_END="1.6124515030726152" CI_START="0.7819882091419217" EFFECT_SIZE="1.1229060794278185" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="69" LOG_CI_END="0.2074866614377337" LOG_CI_START="-0.10679979520512034" LOG_EFFECT_SIZE="0.050343433116306686" MODIFIED="2013-07-08 16:15:50 -0400" MODIFIED_BY="[Empty name]" ORDER="24" O_E="0.0" SE="0.18461342037506356" STUDY_ID="STD-Berenson-2012" TOTAL_1="384" TOTAL_2="383" VAR="0.03408211498257994" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.15745961172984912" CI_END="1.0470437600242943" CI_START="0.6706943771883649" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="OR" EFFECT_SIZE="0.8380014096160328" ESTIMABLE="YES" EVENTS_1="260" EVENTS_2="291" I2="0.0" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="0.019964832910869625" LOG_CI_START="-0.17347533458122416" LOG_EFFECT_SIZE="-0.07675525083517727" METHOD="MH" MODIFIED="2013-07-08 16:15:50 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6915064349986075" P_Q="0.6915064718478343" P_Z="0.11985302674613141" Q="0.15745957207490588" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="766" TOTAL_2="776" WEIGHT="200.0" Z="1.5553907878769182">
<NAME>Consistent OC use: counseling versus standard care</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.073540034619939" CI_START="0.6094203918815557" DF="0" EFFECT_SIZE="0.8088492990654206" ESTIMABLE="YES" EVENTS_1="191" EVENTS_2="214" I2="0.0" ID="CMP-003.02.01" LOG_CI_END="0.0308182448508187" LOG_CI_START="-0.21508301789564505" LOG_EFFECT_SIZE="-0.09213238652241318" MODIFIED="2013-07-08 16:15:50 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.141917339944454" STUDIES="1" TAU2="0.0" TOTAL_1="383" TOTAL_2="388" WEIGHT="100.0" Z="1.4686883456945574">
<NAME>At 3 months</NAME>
<DICH_DATA CI_END="1.0735400346199393" CI_START="0.6094203918815556" EFFECT_SIZE="0.8088492990654206" ESTIMABLE="YES" EVENTS_1="191" EVENTS_2="214" LOG_CI_END="0.03081824485081879" LOG_CI_START="-0.21508301789564513" LOG_EFFECT_SIZE="-0.09213238652241318" MODIFIED="2013-07-08 16:15:50 -0400" MODIFIED_BY="[Empty name]" ORDER="21" O_E="0.0" SE="0.14444361896815472" STUDY_ID="STD-Berenson-2012" TOTAL_1="383" TOTAL_2="388" VAR="0.020863959060617464" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.273108726716651" CI_START="0.618746446756583" DF="0" EFFECT_SIZE="0.8875423939118207" ESTIMABLE="YES" EVENTS_1="69" EVENTS_2="77" I2="0.0" ID="CMP-003.02.02" LOG_CI_END="0.10486549508860489" LOG_CI_START="-0.20848728205181286" LOG_EFFECT_SIZE="-0.05181089348160398" MODIFIED="2013-07-08 16:15:50 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.5168975013936248" STUDIES="1" TAU2="0.0" TOTAL_1="383" TOTAL_2="388" WEIGHT="100.0" Z="0.6481352178045643">
<NAME>At 12 months</NAME>
<DICH_DATA CI_END="1.273108726716651" CI_START="0.618746446756583" EFFECT_SIZE="0.8875423939118207" ESTIMABLE="YES" EVENTS_1="69" EVENTS_2="77" LOG_CI_END="0.10486549508860489" LOG_CI_START="-0.20848728205181286" LOG_EFFECT_SIZE="-0.05181089348160398" MODIFIED="2013-07-08 16:15:50 -0400" MODIFIED_BY="[Empty name]" ORDER="26" O_E="0.0" SE="0.1840649724135444" STUDY_ID="STD-Berenson-2012" TOTAL_1="383" TOTAL_2="388" VAR="0.03387991406959886" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.7496108775012047" CI_END="1.389930073940471" CI_START="0.7908172841829835" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0484182019966348" ESTIMABLE="YES" EVENTS_1="115" EVENTS_2="111" I2="73.33056595284856" I2_Q="73.33049041300156" ID="CMP-003.03" LOG_CI_END="0.14299295186151445" LOG_CI_START="-0.10192384727027383" LOG_EFFECT_SIZE="0.02053455229562028" METHOD="MH" MODIFIED="2013-07-08 16:16:24 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.052820074922114824" P_Q="0.05282041053407793" P_Z="0.742413893723957" Q="3.749600256944756" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="767" TOTAL_2="771" WEIGHT="200.0" Z="0.3286584103723598">
<NAME>Pregnancy (by 12 months)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1845007211299383" CI_START="0.5343355239726073" DF="0" EFFECT_SIZE="0.7955632052017594" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="63" I2="0.0" ID="CMP-003.03.01" LOG_CI_END="0.07353532945950791" LOG_CI_START="-0.2721859518653336" LOG_EFFECT_SIZE="-0.09932531120291288" MODIFIED="2013-07-08 16:15:50 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.2600848599079494" STUDIES="1" TAU2="0.0" TOTAL_1="384" TOTAL_2="383" WEIGHT="100.0" Z="1.1261906236430108">
<NAME>Counseling + phone versus counseling</NAME>
<DICH_DATA CI_END="1.1845007211299383" CI_START="0.5343355239726073" EFFECT_SIZE="0.7955632052017594" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="63" LOG_CI_END="0.07353532945950791" LOG_CI_START="-0.2721859518653336" LOG_EFFECT_SIZE="-0.09932531120291288" MODIFIED="2013-07-08 16:15:50 -0400" MODIFIED_BY="[Empty name]" ORDER="20" O_E="0.0" SE="0.20307839199815472" STUDY_ID="STD-Berenson-2012" TOTAL_1="384" TOTAL_2="383" VAR="0.04124083329655619" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.0915568118057344" CI_START="0.9297942069991401" DF="0" EFFECT_SIZE="1.39453125" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="48" I2="0.0" ID="CMP-003.03.02" LOG_CI_END="0.32046966557868306" LOG_CI_START="-0.03161316397799579" LOG_EFFECT_SIZE="0.14442825080034363" MODIFIED="2013-07-08 16:15:50 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.10783570757524408" STUDIES="1" TAU2="0.0" TOTAL_1="383" TOTAL_2="388" WEIGHT="100.0" Z="1.6079975855410016">
<NAME>Counseling versus standard care</NAME>
<DICH_DATA CI_END="2.0915568118057344" CI_START="0.9297942069991401" EFFECT_SIZE="1.39453125" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="48" LOG_CI_END="0.32046966557868306" LOG_CI_START="-0.03161316397799579" LOG_EFFECT_SIZE="0.14442825080034363" MODIFIED="2013-07-08 16:15:50 -0400" MODIFIED_BY="[Empty name]" ORDER="26" O_E="0.0" SE="0.20681519691970762" STUDY_ID="STD-Berenson-2012" TOTAL_1="383" TOTAL_2="388" VAR="0.04277252567693744" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2013-07-30 15:11:27 -0400" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Structured counseling versus routine counseling</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.6427887528677343" CI_START="0.20370049440703242" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.36185133239831696" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="46" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="-0.19193173086671048" LOG_CI_START="-0.6910079169105604" LOG_EFFECT_SIZE="-0.4414698238886354" METHOD="MH" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="5.253894047532693E-4" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="175" TOTAL_2="175" WEIGHT="100.0" Z="3.4674664080523447">
<NAME>Discontinuation by 6 months</NAME>
<GROUP_LABEL_1>Counseling</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.6427887528677343" CI_START="0.20370049440703242" EFFECT_SIZE="0.36185133239831696" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="46" LOG_CI_END="-0.19193173086671048" LOG_CI_START="-0.6910079169105604" LOG_EFFECT_SIZE="-0.4414698238886354" ORDER="121" O_E="0.0" SE="0.2931598221491215" STUDY_ID="STD-Canto-De-Cetina-2001" TOTAL_1="175" TOTAL_2="175" VAR="0.08594268132250454" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.441623274854657" CI_START="0.16447418977482198" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.2695099818511797" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="76" I2="0.0" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="-0.3549480460701268" LOG_CI_START="-0.7839022443269809" LOG_EFFECT_SIZE="-0.5694251451985539" METHOD="MH" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="1.95465752516356E-7" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="175" TOTAL_2="175" WEIGHT="100.0" Z="5.203598803862849">
<NAME>Discontinuation by 12 months</NAME>
<GROUP_LABEL_1>Counseling</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.441623274854657" CI_START="0.16447418977482198" EFFECT_SIZE="0.2695099818511797" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="76" LOG_CI_END="-0.3549480460701268" LOG_CI_START="-0.7839022443269809" LOG_EFFECT_SIZE="-0.5694251451985539" ORDER="122" O_E="0.0" SE="0.2519698194136025" STUDY_ID="STD-Canto-De-Cetina-2001" TOTAL_1="175" TOTAL_2="175" VAR="0.06348878989532347" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.3693125503398317" CI_START="0.10746482976287305" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.19921875" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="56" I2="0.0" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="-0.43260593347893994" LOG_CI_START="-0.9687336449488865" LOG_EFFECT_SIZE="-0.7006697892139132" METHOD="MH" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="3.0073366342329457E-7" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="175" TOTAL_2="175" WEIGHT="100.0" Z="5.122986641183994">
<NAME>Discontinuation due to menstrual disturbances</NAME>
<GROUP_LABEL_1>Counseling</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.3693125503398317" CI_START="0.10746482976287305" EFFECT_SIZE="0.19921875" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="56" LOG_CI_END="-0.43260593347893994" LOG_CI_START="-0.9687336449488865" LOG_EFFECT_SIZE="-0.7006697892139132" ORDER="123" O_E="0.0" SE="0.3149240715924195" STUDY_ID="STD-Canto-De-Cetina-2001" TOTAL_1="175" TOTAL_2="175" VAR="0.09917717086834735" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.920249258940906" CI_START="0.3638173385425739" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.8358348968105066" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="0.28335760618087114" LOG_CI_START="-0.43911660748822845" LOG_EFFECT_SIZE="-0.07787950065367866" METHOD="MH" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.6726230550036046" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="175" TOTAL_2="175" WEIGHT="100.0" Z="0.42255076659409985">
<NAME>Discontinuation due to other medical reasons</NAME>
<GROUP_LABEL_1>Counseling</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.920249258940906" CI_START="0.3638173385425739" EFFECT_SIZE="0.8358348968105066" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="13" LOG_CI_END="0.28335760618087114" LOG_CI_START="-0.43911660748822845" LOG_EFFECT_SIZE="-0.07787950065367866" ORDER="124" O_E="0.0" SE="0.4243849294142647" STUDY_ID="STD-Canto-De-Cetina-2001" TOTAL_1="175" TOTAL_2="175" VAR="0.18010256831395044" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="4.016197646296357" CI_START="0.10938734769349662" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.6628131021194605" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-004.05" LOG_CI_END="0.6038150772902825" LOG_CI_START="-0.961032907844138" LOG_EFFECT_SIZE="-0.1786089152769277" METHOD="MH" MODIFIED="2011-01-10 11:03:18 -0500" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.654576546125084" Q="0.0" RANDOM="NO" SCALE="23.88289754397344" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="175" TOTAL_2="175" WEIGHT="100.0" Z="0.4474134798856816">
<NAME>Lost to follow up</NAME>
<GROUP_LABEL_1>Counseling</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.016197646296357" CI_START="0.10938734769349662" EFFECT_SIZE="0.6628131021194605" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.6038150772902825" LOG_CI_START="-0.961032907844138" LOG_EFFECT_SIZE="-0.1786089152769277" ORDER="125" O_E="0.0" SE="0.9191994525904129" STUDY_ID="STD-Canto-De-Cetina-2001" TOTAL_1="175" TOTAL_2="175" VAR="0.8449276336425147" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2013-07-30 15:11:53 -0400" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Daily text-message reminders versus no reminders</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="2.0834643647297937" CI_START="-1.0834643647297937" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.5" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.01" MODIFIED="2011-01-10 11:04:22 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.5359922703503799" Q="0.0" RANDOM="NO" SCALE="8.629529361658939" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="36" TOTAL_2="37" UNITS="" WEIGHT="100.0" Z="0.6188847782736517">
<NAME>Mean number of missed pills (cycle 1)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.0834643647297937" CI_START="-1.0834643647297937" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="3.5" MODIFIED="2011-01-06 14:44:54 -0500" MODIFIED_BY="[Empty name]" ORDER="58" SD_1="3.5" SD_2="3.4" SE="0.8079048274457891" STUDY_ID="STD-Hou-2010" TOTAL_1="36" TOTAL_2="37" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.16182995123678E-32" CI_END="2.818770904146641" CI_START="-1.2187709041466412" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.7999999999999997" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-005.02" MODIFIED="2011-01-06 14:46:41 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="1.0" P_Z="0.4373381828060072" Q="0.0" RANDOM="NO" SCALE="12.422429584671304" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="36" TOTAL_2="37" UNITS="" WEIGHT="100.0" Z="0.7766959511905801">
<NAME>Mean number of missed pills (cycle 3)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.818770904146641" CI_START="-1.2187709041466412" EFFECT_SIZE="0.7999999999999998" ESTIMABLE="YES" MEAN_1="5.8" MEAN_2="5.0" MODIFIED="2011-01-06 14:46:41 -0500" MODIFIED_BY="[Empty name]" ORDER="59" SD_1="4.3" SD_2="4.5" SE="1.030004081743567" STUDY_ID="STD-Hou-2010" TOTAL_1="36" TOTAL_2="37" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2013-07-30 15:19:00 -0400" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Daily educational text messages versus no messages</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.0992230781591332" CI_START="1.1356945230431068" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.5440453855088" ESTIMABLE="YES" EVENTS_1="223" EVENTS_2="182" I2="0.0" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="0.32205859221065325" LOG_CI_START="0.05526153137730562" LOG_EFFECT_SIZE="0.18866006179397943" METHOD="MH" MODIFIED="2013-07-30 15:19:00 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.005573074459881336" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="346" TOTAL_2="337" WEIGHT="100.0" Z="2.7718965515011598">
<NAME>OC use (continuation) at 6 months</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors [experimental]</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors [control]</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.0992230781591332" CI_START="1.1356945230431068" EFFECT_SIZE="1.5440453855088" ESTIMABLE="YES" EVENTS_1="223" EVENTS_2="182" LOG_CI_END="0.32205859221065325" LOG_CI_START="0.05526153137730562" LOG_EFFECT_SIZE="0.18866006179397943" MODIFIED="2013-07-29 15:31:22 -0400" MODIFIED_BY="[Empty name]" ORDER="34" O_E="0.0" SE="0.156717914200259" STUDY_ID="STD-Casta_x00f1_o-2012" TOTAL_1="346" TOTAL_2="337" VAR="0.024560504631279737" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.0749958290882824" CI_START="1.1333103137416667" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.5334973668307001" ESTIMABLE="YES" EVENTS_1="203" EVENTS_2="162" I2="0.0" I2_Q="0.0" ID="CMP-006.02" LOG_CI_END="0.31701722808147825" LOG_CI_START="0.05434884110215096" LOG_EFFECT_SIZE="0.1856830345918146" METHOD="MH" MODIFIED="2013-07-29 16:32:17 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.005587787984335694" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="346" TOTAL_2="337" WEIGHT="100.0" Z="2.771038148330382">
<NAME>No OC interruptions &gt; 7 days (by 6 months)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors [experimental]</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors [control]</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.074995829088282" CI_START="1.1333103137416667" EFFECT_SIZE="1.5334973668307001" ESTIMABLE="YES" EVENTS_1="203" EVENTS_2="162" LOG_CI_END="0.31701722808147814" LOG_CI_START="0.05434884110215096" LOG_EFFECT_SIZE="0.1856830345918146" MODIFIED="2013-07-29 16:31:48 -0400" MODIFIED_BY="[Empty name]" ORDER="36" O_E="0.0" SE="0.1542927107411422" STUDY_ID="STD-Casta_x00f1_o-2012" TOTAL_1="346" TOTAL_2="337" VAR="0.023806240587849782" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2013-07-30 15:11:54 -0400" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Intensive reminders versus written appointment cards</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.823915102000389" CI_START="0.6714472026074525" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.106644790812141" ESTIMABLE="YES" EVENTS_1="71" EVENTS_2="69" I2="0.0" I2_Q="0.0" ID="CMP-007.01" LOG_CI_END="0.26100461930442825" LOG_CI_START="-0.17298813119738363" LOG_EFFECT_SIZE="0.044008244053522313" METHOD="MH" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.6910038356937671" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="124" TOTAL_2="126" WEIGHT="100.0" Z="0.3974931529064453">
<NAME>Discontinuation at 12 months</NAME>
<GROUP_LABEL_1>Intensive reminders</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.823915102000389" CI_START="0.6714472026074525" EFFECT_SIZE="1.106644790812141" ESTIMABLE="YES" EVENTS_1="71" EVENTS_2="69" LOG_CI_END="0.26100461930442825" LOG_CI_START="-0.17298813119738363" LOG_EFFECT_SIZE="0.044008244053522313" ORDER="132" O_E="0.0" SE="0.2549294899435266" STUDY_ID="STD-Keder-1998" TOTAL_1="124" TOTAL_2="126" VAR="0.06498904484286662" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.630671308440964" CI_START="0.215655206841754" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.7532051282051282" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="52" I2="0.0" I2_Q="0.0" ID="CMP-007.02" LOG_CI_END="0.4200665881663141" LOG_CI_START="-0.6662400516597271" LOG_EFFECT_SIZE="-0.12308673174670652" METHOD="MH" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.6569287974105877" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="53" TOTAL_2="57" WEIGHT="100.0" Z="0.44415739047111086">
<NAME>On-time injections of those who continued DMPA</NAME>
<GROUP_LABEL_1>Intensive reminders</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.630671308440964" CI_START="0.215655206841754" EFFECT_SIZE="0.7532051282051282" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="52" LOG_CI_END="0.4200665881663141" LOG_CI_START="-0.6662400516597271" LOG_EFFECT_SIZE="-0.12308673174670652" ORDER="133" O_E="0.0" SE="0.6381018975384078" STUDY_ID="STD-Keder-1998" TOTAL_1="53" TOTAL_2="57" VAR="0.40717403164211674" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.4427016898793101" CI_START="0.5229913154350878" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.8686313686313686" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="52" I2="0.0" I2_Q="0.0" ID="CMP-007.03" LOG_CI_END="0.15917654049578456" LOG_CI_START="-0.2815055227769594" LOG_EFFECT_SIZE="-0.0611644911405874" METHOD="MH" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.5863956337622549" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="124" TOTAL_2="126" WEIGHT="100.0" Z="0.5440666174519343">
<NAME>On-time injections overall</NAME>
<GROUP_LABEL_1>Intensive reminders</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.4427016898793101" CI_START="0.5229913154350878" EFFECT_SIZE="0.8686313686313686" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="52" LOG_CI_END="0.15917654049578456" LOG_CI_START="-0.2815055227769594" LOG_EFFECT_SIZE="-0.0611644911405874" ORDER="134" O_E="0.0" SE="0.2588588253778043" STUDY_ID="STD-Keder-1998" TOTAL_1="124" TOTAL_2="126" VAR="0.06700789147597658" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.119289005283964" CI_START="0.7528788490186219" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.263157894736842" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="42" I2="0.0" I2_Q="0.0" ID="CMP-007.04" LOG_CI_END="0.3261901850456743" LOG_CI_START="-0.1232749035281202" LOG_EFFECT_SIZE="0.10145764075877703" METHOD="MH" MODIFIED="2011-01-03 16:27:18 -0500" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.37624059597633086" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="124" TOTAL_2="126" WEIGHT="100.0" Z="0.8848443489775413">
<NAME>Loss to follow up</NAME>
<GROUP_LABEL_1>Intensive reminders</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.119289005283964" CI_START="0.7528788490186219" EFFECT_SIZE="1.263157894736842" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="42" LOG_CI_END="0.3261901850456743" LOG_CI_START="-0.1232749035281202" LOG_EFFECT_SIZE="0.10145764075877703" ORDER="135" O_E="0.0" SE="0.26401801791631785" STUDY_ID="STD-Keder-1998" TOTAL_1="124" TOTAL_2="126" VAR="0.06970551378446115" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2013-09-04 10:25:06 -0400" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2013-09-04 10:25:06 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2013-07-24 04:30:03 -0400" MODIFIED_BY="[Empty name]">Search strategies, 2013</TITLE>
<APPENDIX_BODY MODIFIED="2013-09-04 10:25:06 -0400" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">MEDLINE via PubMed (01 Sep 2010 to 04 Sep 2013)</HEADING>
<P>(counseling[title/abstract word] OR reminders[title/abstract word] OR "peer counseling"[title/abstract word]) AND (compliance[title/abstract word] OR adherence[title/abstract word] OR discontinuation[title/abstract word] OR continuation[title/abstract word] OR acceptability[title/abstract word]) AND ((depot medroxyprogesterone acetate[title/abstract word] OR contraceptives, oral[MeSH]) OR (contracep* AND implant*) OR norplant[title/abstract word] OR jadelle[title/abstract word] OR implanon[title/abstract word] OR "sino implant"[title/abstract word] OR sino-implant[title/abstract word] OR "subdermal implant"[title/abstract word] OR (contracept* AND injectable*) OR (vagina* AND ring) OR (contraceptive agents and ring) or (contraceptive devices and (ring or patch)) OR "transdermal contraceptive patch"[title/abstract word] OR "NET-EN"[title/abstract word] OR "Mesigyna"[title/abstract word] OR Cyclofem[title/abstract word] OR "intrauterine system"[title/abstract word] OR IUD[title/abstract word] OR IUS[title/abstract word]) AND Clinical Trial[ptyp]</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">CENTRAL (2010 to 08 Jul 2013)</HEADING>
<P>Title, Abstract, Keywords: contracept*<BR/>AND Title, Abstract, Keywords: counsel* OR educat* OR intervention*<BR/>AND Title, Abstract, Keywords: compliance OR acceptability OR continu* OR discontinu* OR adhere*</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">POPLINE (2010 to 08 Jul 2013)</HEADING>
<P>(counsel* OR reminder*) AND (compliance OR adherence OR acceptability OR discontinuation OR continuation) AND ((oral AND contracept*) OR Depot medroxyprogesterone acetate OR NORPLANT OR implant* OR (injectable AND contracept*) OR (vagina* AND ring) OR NET-EN OR Mesigyna OR Cyclofem OR (intrauterine OR IUD OR IUS) OR (contracept* AND patch))</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">EMBASE (01 Apr 2008 to 08 Jul 2013)</HEADING>
<P>'counseling'/exp OR reminder AND ('compliance'/exp OR acceptability OR acceptors OR acceptance OR discontinuation OR continuation OR adherence) AND ('norplant'/exp OR implant* OR injectable* OR inject* OR ('oral'/exp AND contracept*) OR 'medroxyprogesterone'/exp OR (vagina* OR contracep AND ring) OR (contracept* AND patch) OR 'iud'/exp OR ius OR 'intrauterine'/exp) AND ([controlled clinical trial]/lim OR [randomized controlled trial]/lim)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">ClinicalTrials.gov (01 Oct 2010 to 08 Jul 2013)</HEADING>
<P>Search terms: (counseling OR reminders) AND (compliance OR acceptability OR continuation OR discontinuation OR adherence)<BR/>Study type: Interventional studies<BR/>Condition: NOT (HIV OR diabetes OR glaucoma)<BR/>Intervention: contracept*<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">ICTRP (01 Oct 2010 to 08 Jul 2013)</HEADING>
<P>Condition: contracept*<BR/>Intervention: counsel* OR reminder* OR educat* OR intervention<BR/>Recruitment status: All</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2013-08-14 15:05:57 -0400" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2013-07-24 04:33:20 -0400" MODIFIED_BY="[Empty name]">Search strategies, 2011</TITLE>
<APPENDIX_BODY MODIFIED="2013-08-14 15:05:57 -0400" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">MEDLINE via PubMed (through 06 Jan 2011)</HEADING>
<P>We used the recommended Cochrane search strategy revised for PubMed searches (<LINK REF="REF-Robinson-2002" TYPE="REFERENCE">Robinson 2002</LINK>):<BR/>((randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized controlled trials [mh] OR random allocation [mh] OR double-blind method [mh] OR single-blind method [mh] OR clinical trial [pt] OR clinical trials [mh] OR ("clinical trial" [tw]) OR ((singl* [tw] OR doubl* [tw] OR trebl* [tw] OR tripl* [tw]) AND (mask* [tw] OR blind* [tw])) OR ("latin square" [tw]) OR placebos [mh] OR placebo* [tw] OR random* [tw] OR research design [mh:noexp] OR comparative study [mh] OR evaluation studies [mh] OR follow-up studies [mh] OR prospective studies [mh] OR control* [tw] OR prospective* [tw] OR volunteer* [tw]) NOT (animal [mh] NOT human [mh])) AND (counseling[title/abstract word] OR "intensive reminders"[title/abstract word] OR reminders[title/abstract word] OR "peer counseling"[title/abstract word] OR "structured counseling"[title/abstract word] OR counseling[title/abstract word]) AND (compliance[title/abstract word] OR adherence[title/abstract word] OR discontinuation[title/abstract word] OR continuation[title/abstract word] OR acceptability[title/abstract word]) AND ((depot medroxyprogesterone acetate[title/abstract word] OR contraceptives, oral[MeSH]) OR NORPLANT[title/abstract word] OR implants[title/abstract word] OR "contraceptives, injectable"[title/abstract word] OR "vaginal ring"[title/abstract word] OR "NET-EN"[title/abstract word] OR "Mesigyna"[title/abstract word] OR Cyclofem[title/abstract word] OR "levonorgestrel-releasing intrauterine system"[title/abstract word] OR "transdermal contraceptive patch"[title/abstract word])</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">CENTRAL (through 14 Oct 2010)</HEADING>
<P>contracept* in Title, Abstract or Keywords AND (counsel* OR educat* OR intervention*) in Title, Abstract or Keywords AND (compliance OR acceptability OR continu* OR discontinu* OR adhere*) in Title, Abstract or Keywords</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">POPLINE (through 01 Nov 2010)</HEADING>
<P>counseling &amp; (compliance/ adherence/ acceptability/ discontinuation/ continuation) &amp; (oral contraceptives/ Depot medroxyprogesterone acetate/ NORPLANT/ implants/ injectable contraceptives/ vaginal ring/ NET-EN/ Mesigyna/ Cyclofem/ levonorgestrel-releasing intrauterine system/ transdermal contraceptive patch) &amp; (compar*/ clinical trials/ comparative studies/ random/ double-blind studies)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">ClinicalTrials.gov (01 Jan 2006 to 29 Oct 2010)</HEADING>
<P>Search terms: (counsel* OR educat* OR intervention*) AND (compliance OR acceptability OR continu* OR discontinu* OR adhere*) NOT (non-randomized OR endometrial OR endometrioma OR mifepristone OR misoprostol)<BR/>Condition: NOT (HIV OR diabetes OR glaucoma)<BR/>Intervention: contraceptive OR contraception<BR/>Study type: interventional studies<BR/>Gender: studies with female participants<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">ICTRP (01 Jan 2006 to 29 Oct 2010)</HEADING>
<P>Condition: contraceptive OR contraception<BR/>Intervention: counsel OR counseling OR counselling OR educate OR education OR intervention<BR/>
</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2013-08-14 15:06:20 -0400" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2013-07-24 04:30:18 -0400" MODIFIED_BY="[Empty name]">Search strategies, 2005 and 2008</TITLE>
<APPENDIX_BODY MODIFIED="2013-08-14 15:06:20 -0400" MODIFIED_BY="[Empty name]">
<P>Strategies included MEDLINE, CENTRAL, and POPLINE (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>) as well as those shown below.</P>
<SUBSECTION>
<HEADING LEVEL="4">EMBASE, PsycINFO and Dissertation Abstracts Online</HEADING>
<P>counseling AND (compliance OR user(w)compliance OR acceptability OR acceptors OR acceptance OR discontinuation OR continuation OR adherence) AND(Norplant OR ((implant OR implants OR injectable OR injectables OR drug implant OR drug injection) AND hormonal contraception) OR oral contraceptive agent OR medroxyprogesterone(w)acetate OR vaginal(w)ring OR contraceptive(w)patch OR (levonorgestrel AND (IUD OR IUS OR intrauterine device OR intrauterine(w)system)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">LILACS</HEADING>
<P>Counseling OR intensive reminders OR "peer counseling" OR "structured counseling" [Words] and Compliance OR discontinuation OR continuation OR acceptability OR patient acceptance of health care [Words]</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">African Index Medicus</HEADING>
<P>(Counseling or counselling or reminders) NOT (AIDS or HIV)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">IMEMR</HEADING>
<P>counseling or reminders</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>